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Abstract 
The tooth is a common research model used in the study of molecular mechanisms of 
organ development. The canonical Wnt signalling pathway is known to play an 
imperative role in tooth pattern development and cell differentiation, which is 
responsible for tooth root formation. Research in the area of periodontal regeneration 
has also revealed similar cellular interactions and signalling activation. Cementum 
regeneration is one of the most difficult and challenging phases during periodontal 
tissue regeneration. Although there are increasing studies on cementum regeneration 
using various techniques including novel cell-based approaches, cementum 
regeneration is still not established or fully understood, nor are the molecular 
mechanisms. The purpose of this project was to address the question whether 
canonical Wnt signalling pathway regulates cementum regeneration and repair in 
vitro and in vivo. This research also endeavoured to develop suitable biomaterials for 
the cementum/periodontal tissue engineering in vitro with respect to the regulation of 
canonical Wnt signalling pathway. 
For this purpose, a rat periodontal defect model was created to investigate the 
periodontal wound healing process. Micro-computed tomography (Micro-CT) 
scanning and histology studies further confirmed the periodontal defect and the 
healing process. Afterwards, the activation of canonical Wnt signalling at the 
periodontal defect was performed by local delivery of either neutralized anti-
sclerostin antibody (Scl-Ab) or a Wnt enhancer (lithium chloride, LiCl) or lentivirus 
particles with gene of β-catenin (LV-Ctnnb). The results showed that activation of 
canonical Wnt signalling could induce formation of new cementum and well-
oriented periodontal ligament fibres compared to the non-treatment group. This study 
further conducted in vitro experiments to explore whether canonical Wnt signalling 
regulates cementogenic differentiation of human periodontal ligament cells 
(hPDLCs) with gain-of-function analysis in respect to canonical Wnt signalling 
pathway. Western blotting and qRT-PCR assays were utilized to investigate the 
effect of canonical Wnt signalling pathway in cell proliferation and 
osteogenic/cementogenic differentiation in hPDLCs. The data demonstrated that 
canonical Wnt signalling pathway was involved in the progress of hPDLCs 
iv  
osteogenic differentiation towards cementoblast-like cells. These findings thus 
provide clear evidence that canonical Wnt signalling pathway plays an important role 
during cementum regeneration in vivo and in vitro, suggesting that canonical Wnt 
signalling could be a potential target for periodontal regeneration. 
Subsequently, canonical Wnt signalling activator of LiCl was incorporated into 
mesoporous bioactive glass (MBG) scaffolds. This approach yielded scaffolds that 
had a favourable composition, microstructure and mesopore properties for cell 
attachment, proliferation, and cementogenic differentiation of human periodontal 
ligament-derived cells (hPDLCs). The results showed that Li
+
 ions, when 
incorporated into MBG scaffolds at the concentration of 5%, enhanced the 
proliferation and cementogenic differentiation of hPDLCs.  
Subsequent experiments were performed to also determine whether Li-containing β-
tricalcium phosphate (Li-β-TCP) bioactive ceramics could effectively induce this 
differentiation for both hPDLCs and human bone marrow stromal cells (hBMSCs). 
β-TCP is a widely accepted bone substitute material compared with MBG even 
though its bioactivity is lower than MGB. The results showed that Li-β-TCP 
bioceramic disks supported cell attachment and proliferation, and significantly 
enhanced bone/cementum-related gene expression and canonical Wnt signalling 
pathway activation in both hPDLCs and hBMSCs. These findings demonstrated that 
Li-β-TCP bioceramics possess excellent in vitro osteogenic/cementogenic 
stimulation properties, indicating that they could act as a promising biomaterial for 
bone/cementum regeneration. 
In conclusion, the body of work presented in this thesis has demonstrated that 
activation of canonical Wnt signalling pathway can lead to cementum regeneration in 
vivo and in vitro. Activation of canonical Wnt signalling pathway by bioactive 
materials may provide potential therapeutic strategies for periodontal tissue 
regeneration. 
Keywords: canonical Wnt signalling pathway, rat periodontal defect model, 
periodontal tissue engineering, human periodontal ligament cells, Li-containing 
mesoporous bioactive glass, Li-containing β-tricalcium phosphate  
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 Chapter 1: Introduction 1 
Chapter 1: Introduction 
1.1 BACKGROUND 
The tooth is a common research model used in the study of the molecular 
mechanisms of organ development [1-2]. Tooth formation is a typical epithelial-
mesenchymal interaction with a series of cellular signals between oral epithelium and 
crest-derived mesenchyme [3]. Among all the signals, the canonical Wnt signalling 
pathway is known as an imperative guiding signal system in the embryonic course of 
pattern formation and differentiation responsible for tooth crown and root formation 
[4].  
Periodontium consists of not only soft tissues (gingival and periodontal ligament) but 
also hard tissues (bone and cementum). Current non-surgical or surgical treatments 
cannot achieve regeneration of the lost tissues, including periodontal ligament, 
alveolar bone and cementum, thus resulting in inferior aesthetics and function [5-6]. 
The goal of regenerative periodontal therapy is to reform a tooth supporting tissues, 
which have been lost following dental trauma or periodontal disease. Therefore, 
novel techniques are required for successful regeneration, which is difficult as the 
periodontium complex structure consists of soft and hard tissues. The formation of 
new cementum is the most important event in periodontal regeneration, but is being a 
unique and poorly understood phenomenon. The regeneration of cementum is crucial 
because fibrous filaments from the periodontal ligament have to be inserted into the 
cementum, thus functionally anchoring the tooth. Although there are increasing 
research efforts concentrating on cementum regeneration using cell sheet techniques 
and other novel cell-based approaches, no establishment or molecular mechanisms of 
cementum regeneration have been reported to date [7]. Therefore, regenerating 
functional cementum in vivo still poses a challenge.  
Along with developments in molecular and cellular biology, knowledge of the 
underlying mechanisms of periodontal tissue engineering techniques has thrown a 
new light on the repair of periodontal complex. The realm of periodontal tissue 
regeneration has a plethora of unanswered questions and challenges, due to the 
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complexity of restoring mineralised and fibrous connective tissues are ultimately to 
be covered by epithelium in a very specific spatial organisation. Wound healing of 
the periodontium follows a highly ordered sequence of events that guides cellular 
morphology, differentiation, migration and proliferation and comprises a series of 
cellular, extracellular and molecular reciprocal interactions [8-9].  
In canonical Wnt signalling, the neutralized sclerostin (a negative Wnt pathway 
regulator) antibody (Scl-Ab) was proven to activate the canonical Wnt signalling to 
promote bone regeneration in fracture healing [10-11]. Lithium chloride (LiCl), 
known as a glycogen synthase kinase 3β (GSK3β) inhibitor, is capable of enhancing 
in vivo bone mass through activation of canonical Wnt signalling pathway in cultured 
calvarial osteoblasts from Lrp5
-/- 
 mice [12], suggesting that activation of the Wnt 
signalling pathway may assist in regeneration of bone and associated periodontal 
tissues. Therefore, it is reasonable to hypothesize that this current knowledge may 
further assist in investigating the regulation of Wnt signalling in periodontal 
regeneration application. 
Biomaterials, such as natural biomaterials, synthetic polymers and bioceramics, have 
been use in clinical practise for treatment of damaged or lost bone for several 
decades [13]. These materials serve as carriers to deliver therapeutic cells and/or 
various related growth factors to restore the periodontium [14-16].  The biomaterials 
have been designed with suitable pore size and greater porosity to maximize the cell 
attachment with the materials [15]. Many methods have been developed to increase 
the efficiency of regenerative capability by combining the growth factors of bone 
morphogenetic proteins (BMPs) and fibroblast growth factors (FGFs) with the 
scaffold, as well as gene transfection [17-18]. However, due to difficulties associated 
with the controlled release of growth factors, the results to date have been 
disappointing, causing an unpredictable degree of vascularization and even 
oncogenesis. Thus, it is of great importance to design a material that can carry other 
easily controlled signalling molecules that are safer than growth factors. 
It is speculated that understanding the role of activation of the Wnt signalling 
pathway in periodontal tissue engineering will enable us in deciphering the molecular 
basis of cementogenesis and cementum regeneration. Furthermore, lithium may be 
applied in the biomaterials to activate canonical Wnt signalling, which could be 
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another new approach for periodontal tissue engineering. However, some major 
concerns in relation to this concept exist in the reconstruction of periodontal tissues, 
namely insufficient understanding of cementogenesis and cementum regeneration, 
biomaterials designs and immunological concerns.  
1.2 PURPOSE OF THIS RESEARCH 
The main purpose of this study was to investigate the role of canonical Wnt 
signalling pathway during cementogenic differentiation in vitro and cementum 
regeneration in vivo; a suitable biomaterial was designed by the activation of 
canonical Wnt signalling for periodontal tissue engineering in vitro.  
1.3 QUESTIONS TO BE ANSWERED 
1. Did activation of canonical Wnt signalling pathway stimulate periodontal 
tissue regeneration in vivo and human periodontal ligament cells (hPDLCs) 
differentiation into cementobolas-like cells in vitro? 
2. Was it possible to activate canonical Wnt signalling in mesoporous bioactive 
glasses (MBG) for in vitro cementogenic differentiation of human periodontal 
ligament cells (hPDLCs)?  
3. Could human bone marrow stromal cells (hBMSCs) be another alternative for 
periodontal tissue engineering? Could we design a new potential material of 
beta-tricalcium phosphate (β-TCP) for periodontal tissue engineering?  
1.4 POSSIBLE OUTCOMES AND SIGNIFICANCE 
Based on the role of canonical Wnt signalling pathway during cementogenesis, the 
concept of activation of Wnt signalling for periodontal regeneration, especially 
cementum regeneration, was emphasized in this project. More knowledge may be 
revealed throughout this project about canonical Wnt signalling pathway and 
cementum interactions. This project was believed to be the first to investigate the 
important role of canonical Wnt signalling during cementogenic differentiation in 
vitro and cementum regeneration in vivo. This project was also a pioneer in the 
design of a biological biomaterial with activation of canonical Wnt signalling for 
periodontal tissue engineering. It may reveal the potential molecular mechanism of 
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periodontal repair that could provide another approach for periodontal repair in the 
clinic. The newly designed biomaterial in this project could be manufactured and 
marketed as a medical product, thereby potentially providing a commercial outcome. 
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Chapter 2: Hypothesis & Aims of 
Research 
2.1 HYPOTHESIS 
Activation of canonical Wnt signalling could enhance cementum regeneration in vivo 
and in vitro; the suitable biomaterials can be designed by activation of canonical Wnt 
signalling for periodontal tissue engineering 
2.2 AIMS OF RESEARCH 
The specific objectives of the study were as follows: 
Aim 1: To investigate regulation of canonical Wnt signalling in cementum 
regeneration using a periodontal defect model and cementogenic differentiation for 
hPDLCs 
Aim 2: To design lithium-containing biomaterials to stimulate canonical Wnt 
signalling for periodontal tissue engineering (divided into two parts) 
2.3 OVERALL RESEARCH DESIGN  
The project was designed as three separate parts, based on the aims described above: 
2.3.1 Part one (Chapter 4): 
To understand the role of canonical Wnt signalling pathway during in vivo 
cementum repair and in vitro cementogenic differentiation for hPDLCs 
Rat periodontal defect establishment  
The periodontal defect was created as described according to the previous 
publication [19]. The mandibles of twelve female Lewis rats were harvested and 
fixed at 7, 14 and 28 days after surgery. Micro-CT was carried out to confirm the 
periodontal defect and analyse the alveolar bone formation. After decalcification, the 
tissues were performed with Hematoxylin & Eosin (H&E) staining. Heidenhain’s 
AZAN trichrome (AZAN) staining was also used to assess the wound healing with 
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blue collagen fibres, cartilage matrix and red cell nuclei. Changes in the structure 
along with the root dentin were analyzed from different groups. Subsequent 
immunohistochemical staining was performed using several specific antibodies to 
identify the cell populations in different groups. 
The activation of the canonical Wnt signalling in rat model 
LiCl, Scl-Ab and lentivirus particles expression β-catenin (LV-Ctnnb) were locally 
injected at the periodontal defect. The mandible from eight female Lewis rats were 
harvested and fixed at 14 days after surgery. Micro-CT was carried out to confirm 
the periodontal defect and analyse the alveolar bone formation. After decalcification, 
the tissues were assessed with H&E and AZAN staining. Changes in the structure 
along with the root dentin were analyzed from different groups. Subsequent 
immunohistochemical staining was performed using several specific antibodies to 
identify the cell populations in different groups. 
Regulation of Wnt signalling in human periodontal ligament cells (hPDLCs) 
Isolation and culture of human PDLCs were performed according to previously 
published protocols [20]. Teeth were obtained from six systemically healthy patients 
(18–25 years old) undergoing third molar extraction surgery. Informed consents were 
given to all patients involved and the research protocol was approved by the Human 
Ethics Committees of Queensland University of Technology, Brisbane, Australia. 
Periodontal ligament tissues were separated from the middle third of the root surface 
using a scalpel and were cultured in a T25 flask in Dulbecco’s Modified Eagle 
Medium (DMEM; Gibco-Invitrogen) supplemented with 10% v/v fetal bovine serum 
(FBS; Thermo Scientific) and 50 U/mL penicillin and 50 mg/mL streptomycin (P/S; 
Gibco-Invitrogen) at 37
o
C in a humidified CO2 incubator. The medium was changed 
after five days and the outgrown cells growing around the PDL tissues were passaged 
at approximately 80% confluence and expanded through two passages to obtain a 
sufficient number of cells for the in vitro assays. Cells at passages P2-P5 were used 
for the study.  
For osteogenic differentiation, cells were cultured in osteogenic differentiation 
DMEM medium which was supplemented with 10% FBS, 50μg/ml ascorbic acid 
(Sigma, Australia), 3mM β-glycerophosphate (Sigma, Australia) and 10nM 
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dexamethasone (Sigma, Australia). To activate canonical Wnt signalling, different 
concentrations of lithium chloride (LiCl at 0, 2.5, 5, 10 and 20 mM) were 
supplemented into osteogenic media in hPDLCs cultures. To further investigate the 
effect of canonical Wnt signalling during this process, LV-Ctnnb was supplemented 
in the osteogenic medium. 
The effect of canonical Wnt signalling in gene/protein expression for hPDLCs  
After 7 days culture under osteogenic differentiation, the expression of relevant 
cementogenic markers of cementum attachment protein (CAP), canonical Wnt 
signalling molecules of axis inhibition protein 2 (AXIN2) and beta-cadherin-
associated protein (β-catenin, CTNNB) was determined by RT-qPCR, western blot 
and immunohistochemistry staining, and compared between differentiated hPDLCs 
and human osteoblasts (hOB) from jaw bone without LiCl or LV-Ctnnb. 
2.3.3 Part two (Chapter 5):  
To design mesoporous bioactive glass (MBG) scaffolds for periodontal tissue 
engineering 
Preparation of Li-MBG scaffolds 
Porous lithium-containing mesopore-bioglass (Li-MBG) scaffolds were prepared by 
incorporating Li (molar: 0, 2 and 5%) into MBG. The large-pore structure and inner 
microstructure of the calcined Li-MBG scaffolds were characterized by scanning 
electron microscopy (SEM) and transmission electron microscopy (TEM). 
Cell attachment and proliferation on Li-MBG scaffolds 
hPDLCs at passages P2–P5 were used for the study. At an initial density of 
1×10
5
cells/scaffold, hPDLCs were cultured on 5×5×5 mm Li-MBG scaffolds placed 
in 48-well culture plates with osteogenic differentiation medium. After culturing for 
7 days, SEM analysis, MTT assay, relative ALP activity and calcium assay were 
performed to investigate the cell morphology, proliferation and differentiation, 
respectively.  
The effect of Li-MBG scaffolds on cementogenic differentiation via Wnt signalling  
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The cells on MBG and Li-MBG scaffolds were collected after culturing for 3 and 7 
days. The gene expression for cementogenic markers (CEMP1 and CAP) and Wnt 
signalling molecules (AXIN2 and CTNNB) was measured by qRT-PCR. 
2.3. 4 Part three (Chapter 6):  
Li-β-TCP ceramics as another potential material for periodontal tissue 
engineering 
Preparation and characterization of 5Li-β-TCP bioceramic powders and disks 
The Li-containing β-TCP (5Li-β-TCP) powders and ceramic disks were synthesized 
by a chemical precipitation method in which 5% molar Ca was substituted with Li. 
The particle size of powder and crystal phase and surface morphology of the sintered 
ceramic discs were characterized by X-ray diffraction (XRD) and SEM. 
The cell morphology and proliferation of hPDLCS and hBMSCs on 5Li-β-TCP 
bioceramic disks 
hPDLCs and hBMSCs were seeded on 5Li-β-TCP ceramic disks at the initial seeding 
density of 10
5 
cells per disk in 48-well plates and cultured under osteogenic induction 
medium. The cells cultured in β-TCP ceramics and blank wells were used as a 
control in this study. The cell morphology on the disks was observed by SEM and 
confocal laser scanning microscopy (CLSM). MTT assay and relative ALP activity 
were carried out to investigate the cell proliferation and differentiation for both 
hPDLCs and hBMSCs on 5Li-β-TCP bioceramic disks. 
The cementogenic/osteogenic differentiation of hPDLCS and hBMSCs on 5Li-β-
TCP bioceramic disks 
hPDLCs and hBMSCs were collected from 5Li-β-TCP and β-TCP bioceramic disks; 
qRT-PCR and western blotting were carried out for cementogenic/osteogenic 
markers (ALP, OPN, OCN, CEMP1, CAP) and canonical Wnt signalling markers 
(WNT3a, LRP5, AXIN2, CTNNB) after 7 days culturing in osteogenic medium. 
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3.1 THE ROLE OF THE CANONICAL WNT SIGNALLING PATHWAY IN 
DEVELOPING TEETH 
3.1.1 Brief review of tooth molar formation  
Teeth have long been regarded as the most ideal model organs for use in research, 
because they can be easily observed, obtained to be manipulated, can be cultured in 
vitro and explanted to other ectopic positions to get the recognizable structure [2]. 
Tooth formation is typical of epithelial-mesenchymal interactions with a series of 
inductive signals transferred between the neural crest-derived mesenchyme and oral 
epithelium [3]. Depending on different species, teeth can be formed from ectoderm 
only or both endoderm and ectoderm [21].  
The embryonic tooth molar formation 
In mice, future dental mesenchyme is determined by the embryo midbrain and 
hindbrain-derived neural crest cells at embryonic day 8.5 (E8.5) [22-24]. Then the 
determination of tooth type starts at the first gill arch around E10.5, following by the 
appearance of the starting signs for tooth development on maxilla and mandible [25-
26]. At E11.5, the first sign of tooth development can be seen as an obvious 
thickening of the oral epithelium with distinct morphological characteristics. During 
this period, the dental epithelial cells transform their morphology from cuboidal to 
high columnar, forming tooth primordia along the apical-basal axis. The thickened 
epithelium invaginates into neural-crest-derived mesenchyme to form the placodes 
with a U-shaped area known as the dental laminar. At the bud stage of E12.5 to 
E13.5, the budding dental epithelium is accompanied by the subsequently condensed 
dental mesenchyme cells around the bud to form dental papilla, while the dental 
epithelial cells maintain columnar shape [27]. The epithelium undergoes proliferation 
and extends further to the mesenchyme to form a cap at the E14.5, which is thought 
to be induced by enamel knot. The enamel knot, a centre of non-proliferating 
epithelial cells, expresses a set of unique signalling molecules involving all the 
pathway families, and is therefore considered to control the patterning of the tooth 
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cusp. These growth factors regulate the proliferation of neighbouring epithelial cells, 
leading to the uneven growth of dental epithelium to a cap shape. It is at this stage 
that the tooth crown development is initiated [28]. Following by this, mesenchymal 
cells differentiate into dentin-producing odontoblasts and the adjacent dental 
epithelium differentiates into enamel-producing ameloblasts at bell stage of E16.5. 
Then these two types of cells further elongate and the nuclei move to the other basal 
axis to begin secreting dentin and enamel. The dental follicle, which is mesenchymal 
part of the tooth germ, gives rise to periodontal structures including periodontal 
ligament (PDL), alveolar bone and cementum. In addition, the neural-crest-derived 
mesenchyme not only can form the dentin-producing odontoblasts, but also the 
future alveolar bone [29-30]. 
Human tooth development shares great similarity with that of early mouse 
development, including dental lamina, the bud and the cap stages shown in Figure 3-
1 [1]. At the 5
th
 week of human gestation, tooth germ commences with a potential 
epithelium shape change from cubic to columnar, and subsequently form a U-shaped 
band around the upper and lower jaw, that is dental laminar. Following this, at the 7
th
 
week of embryonic development, continuous but asymmetric proliferation in the 
laminar epithelium entrap into the below dental mesenchyme, leading to bud 
structure with 10 presumptive deciduous teeth at intervals. Thereafter, from the 9
th
 to 
10
th
 week, human deciduous tooth bud invaginates into the mesenchyme, generating 
the primary enamel knot to control the tooth cusp formation. At the same time, the 
permanent tooth germ can be formed along the superficial side of the tooth bud. 
However, there is a major difference between the human tooth development and 
other mammals. A prominent epithelial branch can be produced by dental 
mesenchymal bud around the lingual or buccal side, which is the prospective 
permanent tooth bud epithelium. It can also interact with mesenchyme to become 
permanent tooth germs as well as the deciduous epithelium, but permanent tooth 
germ will pause at the late bell stage until the primary teeth are replaced. 
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Tooth root development 
During the late bell stage, it is known that the size and shape of the crown become 
permanent as the ameloblasts and odontoblasts secrete the mineralized matrix of 
enamel and dentin, respectively. The tooth development has demonstrated that the 
crown is always covered by the epithelium, but the epithelia stem cell niche is lost 
when the root formation starts among the non-continuously growing teeth including 
all human teeth [31]. 
Following the completion of crown formation, an epithelium called Hertwig’s 
Epithelial Root Sheath (HERS) directs root growth and participates in the root 
development and the completion of tooth organ. HERS, known as a morphologically 
boundary structure of two dental ectomesenchymal tissues: dental papilla and dental 
follicle, continuously proliferate and are invaded by the epithelia cells covering the 
surface of the root termed as epithelia cell rests of Malassez. Both HERS and 
Malassez have the limited proliferative competence, but more findings indicate that 
Figure 3-1. The early stages of molar 
tooth development in the mouse and 
human embryos [1]. (A-D) the mouse 
molar tooth germ at the lamina stage 
(A), the early bud stage (B), the late 
bud stage (C), and the cap stage (D). 
(E-H) The human molar tooth germ at 
the lamina stage (E), the early bud 
stage (F), the late bud stage (G), and 
the cap stage (H). The presence of the 
secondary tooth germ (STG) in (G). 
Abbreviation: DE, dental epithelium; 
DM, dental mesenchyme; DP, dental 
papilla; EK, enamel knot; STG, 
secondary tooth germ.  
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the interaction between them plays an important role during root formation including 
the bio-mineralization for cementogenesis and root dentin formation [32-35]. 
After the initiation of root formation, interaction between HERS and dental follicle 
cells leads to the development of periodontium cementoblasts, root osteoblasts and 
fibroblasts derived from the mesenchymal cells of dental follicle [23, 36]. Then the 
cementoblasts differentiate into cementum that covers the root surface and the 
fibroblasts form periodontal ligament fibres that are inserted in cementum adjacent to 
the root dentin, and alveolar bone will be produced by osteoblasts [37-38]. Then, 
supporting tooth root structure forms with the complete periodontal tissues including 
periodontal ligament, cementum and alveolar bone. 
3.1.2 Molecular network in developing tooth 
Classical studies have indicated that mammalian tooth development depends on the 
continuous molecular interactions between the dental epithelium and mesenchyme 
derived from the cranial neural crest in various mesoderms [3]. It is clear that 
embryonic cell and tissue interactions are mediated by diffusible protein signalling 
molecules known as growth factors. Soluble growth factors play a critical role in the 
process of interaction between dental epithelium and neural-crest-derived 
mesenchyme [28, 39]. The role of the growth factor is to activate a series of 
intracellular reactions to produce transcription factors in the neighbouring target cells 
or tissues. The transcription factors are intracellular proteins combined with the DNA 
specific region, thereby activating or inhibiting downstream related genes expression. 
It is temporal and spatial expression of growth factors and transcription factors that 
leading to a continuous and mutual induction during the organ development [2, 40]. 
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Figure 3-2. Gene and signalling pathways involved in tooth formation including early 
embryonic and root development [3]. Four classical signalling pathways have been found to 
have an imperative role in the tooth formation.  
Growth factors regulate the interaction during odontogenesis 
It has been clear that growth factors mediate the inductive interaction between cells 
and tissues during the tooth development. Prominent among those are hedgehog (Hh) 
families, bone morphogenetic proteins (BMPs), fibroblast growth factor (FGFs) and 
Wnt (wingless-type MMTV integration site family member) families [41-43]. These 
extracellular ligands function antagonistically/synergistically to pattern the organs 
development, through binding to their particular cell membrane-bound receptors. 
And then the complex can activate intracellular signals, leading to signal 
transduction into the nucleus where potential transcription factors can be activated, 
eventually lead to target genes expression [44]. Recent findings have revealed that all 
the ligands, their receptors and other key signalling molecules are involved with 
mediating the epithelial-mesenchymal interactions in the tooth development [45-46].  
Wnts gene family has a large number of members that participate in cell proliferation 
and differentiation during many organs formation [47]. Hedgehog protein family 
(Hhs) consists of three members in vertebrates: sonic hedgehog (Shh), india 
hedgehog (Ihh) and desert hedgehog (Dhh). Among the three members, Shh is the 
only ligand expressed in the early embryonic tooth development and has been 
implicated in tooth patterning and growth through short-range and long-distance 
activation of downstream genes [48-49].  
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The role of transcription factors in tooth development 
In the process of organ development, transcription factors can recognize and bind to 
the specific DNA region on the specific gene transcriptional regulatory region 
(promoter), which inhibits or activates relative gene expression. RNA in situ 
hybridization (ISH) is a type of hybridization that uses a labelled complementary 
RNA probe to localize a specific RNA sequence in a portion or section of tissue. 
RNA ISH results have demonstrated that many transcription factors and growth 
factors often have overlapped expression in several regions during tooth 
development, suggesting the existence of potential interaction between them [47]. A 
series of homeobox genes, have played an imperative role in the process of tooth 
development, and a homeobox gene code hypothesis for the tooth pattern formation 
was raised [26, 48, 50-51]. The overlapping expression areas of homeobox genes 
may subdivide the jaw into upper and lower regions in order to specify the tooth’s 
position. 
Signalling network involved in regulation of tooth formation 
It is well known that BMP, FGF, Hhs and Wnt signalling pathways have always 
played an imperative role in cell differentiation and proliferation in epithelial and 
mesenchymal tissues during tooth morphogenesis.  
Bone morphogenetic proteins (BMPs) belong to the TGF-β superfamily. The findings 
demonstrated that many members, such as BMP2, BMP3, BMP4, BMP5, BMP6, 
BMP7, are involved in the occurrence of teeth, but many studies have shown that 
Bmp4 is the most critical gene to mediate the interactions between epithelium and 
mesenchyme [27].  
Several FGF family members have been detected with the expression in the early 
stages of tooth development and also can control all the steps during the teeth 
development from the teeth initiation to the last cusp formation [42].  
Hedgehog gene was originally discovered in mutant fruit flies. Among the three 
members of Hh family in vertebrates, Shh is the only Hh ligand to be detected in 
early tooth development [48]. Odent etc. have found that Shh was expressed in 
human neural tube substrate, spinal cord, lungs, teeth and limbs development. In the 
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Shh knockout mice, the mineralization of enamel and dentin is still preserved, but the 
level and polarity of ameloblast and odontoblast would be severely damaged [52].  
A number of Wnt genes are found to express in the developing tooth germ, however, 
most Wnt genes have limited expression in the dental epithelium. Wnt10a and 
Wnt10b expression can be detected in thickening epithelial of the molars and incisors 
at E11.5. However, expression of both Wnt10a and Wnt10b was only confined in the 
enamel knot of cap stage at E14.5 [53]. In contrast, expression of Wnt5a, sFrp2, and 
sFrp3 are limited in the dental mesenchyme [54]. The absence of certain Wnt genes 
in knockout mice, such as Wnt1, Wnt2, Wnt3, Wnt3a or Wnt5a, can cause premature 
embryonic death [55]. 
3.1.3 The canonical Wnt signalling in developing tooth 
The Wnt signalling pathway plays essential roles in cell maintenance, proliferation 
and differentiation during the entire tooth development. The Wnt pathway involves a 
large number of proteins known as extracellular Wnt signalling ligands and their 
interactions with receptors on target cells, which can trigger the cell physiological 
responses [31].  
Brief overview of Wnt pathways 
Wnt proteins are paracrine-signalling molecules and have at least 19 family members 
in mammals. They can be placed into 12 subfamilies and form a family of 
evolutionarily conserved secreted glycoproteins [56]. Traditionally, mammalian 
Wnts can be subdivided into two groups based on their abilities of whetter activate 
canonical Wnt signalling. Members of the Wnt1 class (Wnt1, Wnt3, WNT3A, 
Wnt7A, Wnt7B, Wnt8A) have been considered to effectively activate canonical β-
catenin pathway, whereas members of the Wnt5a class (Wnt4, Wnt5A, and Wnt11) 
have been considered poor activators or even inhibitors of the canonical pathway as 
they act through the non-canonical (β-catenin independent) pathways [57]. Wnt 
ligands activate several known pathways: the Wnt/β-catenin or canonical signalling 
pathway, the Wnt/Ca
2+
 pathway involving Protein Kinase A and the non-canonical 
planar cell polarity (PCP) pathway [58].  
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The canonical Wnt pathway involved with the stabilization and accumulation of β-
catenin in the nucleus. In the absence of Wnt ligands, cytoplasmic β-catenin is 
phosphorylated by glycogen synthase kinase 3β (GSK3β) and is associated with 
adenomatous polyposis coli (APC) and Axin proteins, leading to the destruction of β-
catenin via the ubioquitination-proteosome degradation. When Wnt proteins bind to 
the cell-surface receptors of the Frizzled family and/or low-density lipoprotein 
(LDL) receptor known as LRP5/6, ligands-receptors complex could activate 
dishevelled protein homolog Dvl (Dsh in Drosophila) family proteins. Dvl protein is 
a key component of a membrane-associated Wnt receptor complex which inhibits the 
proteins complex including Axin, GSK-3, and APC. The inhibition of this "β-catenin 
destruction complex" can stabilize a pool of cytoplasmic β-catenin, and some 
accumulated β-catenin is able to enter the nucleus where it interacts with TCF/LEF 
(T cell factor/lymphoid enhancer factor) family transcription factors to promote 
specific gene expression (Fig. 3-3) [59]. 
During the past 20 years, increasing findings revealed that β-catenin-independent 
Wnt signalling pathways have been identified to control aspects of gastrulation 
movements. The non-canonical Wnt signalling pathway, also termed the atypical 
Wnt-Frizzled signalling pathway, has two intracellular signalling cascades that 
consist of the Wnt/Ca
2+
 signalling pathway and the Wnt/PCP signalling pathway. 
While the signalling events of the β-catenin-independent pathway are relatively 
poorly defined, partly because there are at least three mechanisms branches, which 
also overlap with other signalling pathways (Fig. 3-3) [60]. Potential mechanisms of 
non-canonical Wnt signal transduction are also quite diverse, including signalling 
through calcium flux, JNK, and both small and heterotrimeric G proteins. There are 
indications that vertebrate non-canonical Wnt signalling may also be involved in 
processes as diverse as cochlear hair cell morphology, heart induction, dorsoventral 
patterning, tissue separation, neuronal migration, and cancer [61]. 
The Wnt/Ca
2+
 pathway regulate cell fate determination, cell migration, and axon 
guidance and collaborate with the PCP pathway in regulating tissue polarity. In 
Wnt/Ca
2+
 signalling pathway, Wnt proteins (consisting Wnt1, Wnt5a and Wnt11)  
bind with frizzled homologs resulting in activating phospholipase C (PLC). Then 
PLC leads to increased intracellular Ca
2+ 
and activation of calcium calmodulin kinase 
II (CaMKII), protein kinase C (PKC) and calcineurin. CaMKII and PKC inhibit the 
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canonical Wnt signalling. PKC also activates Cdc42 regulating cytoskeletal 
dynamics during convergent extension. Calcineurin activates NFAT which affects 
gene transcription controlling cell fate and cell migration [62].  
The non-canonical planar cell polarity (PCP) pathway is best characterised in 
Drosophila where it controls the remodelling of the cytoskeleton, tissue polarity, 
coordinated cell migration and axon guidance via a β-catenin-independent manner 
[63]. For Wnt/PCP signalling, Wnts proteins bind to Frizzled receptors, followed by 
activating Rho/Rac small GTPase and Jun N-terminal Kinase (JNK) via Dvl and 
Diego (Dgo) to assist in the subsequent regulation of cytoskeletal organization and 
gene expression. Dvl is connected via Daam1 to downstream effectors of Rho and 
Rho-Associated Kinase (ROCK), resulting in actin stress fibre formation. Dvl also 
activated Rac, leading to the protrusion of actin-based lamellipodia and c-Jun-
dependent transcription. Activation of Rac1, Cdc42 and JNK also leads to 
stabilisation of microtubule filaments. Thus, direct interaction of Dvl with both 
RhoA and Rac1 is fundamental to the regulation of cell polarity through the 
remodelling of the actin and microtubule cytoskeletons [54]. 
 
Figure 3-3. Wnt signalling pathways [60]. In the canonical Wnt signalling pathway, in the 
absence of Wnt signalling, β-catenin is in a complex with axin/APC/GSK3β, and gets 
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phosphorylated for degradation. In the presence of Wnt signalling, β-catenin is uncoupled 
from the degradation complex and translocates to the nucleus, where it binds TCF/LEF 
transcription factors, thus activating target genes controlling cell fate and proliferation. The 
non-canonical Wnt/Ca
2+
 pathway involves intracellular Ca
2+
 increase which activates 
CaMKII, PKC and calcineur in controlling cell fate and cell migration. Non-canonical PCP 
signalling mediates cytoskeletal changes through activation of RhoA and ROCK via Daam1, 
which leads to actin polymerisation, and Rac1 and JNK, which leads to microtubule 
stabilisation.  
Wnt pathway antagonists 
In the canonical Wnt signalling pathway, Wnt receptors complex that activate 
intracellular cascade event contains two catalogues: a member of Frizzled (Fzd) 
family (10 family members of these seven-transmembrane-span proteins in human) 
and either of co-receptors LRP5/6 (two single-span transmembrane proteins). 
However, activation of non-canonical Wnt pathways is mediated by Fzd family 
receptors; it is not clear whether LRP5/6 are required in these non-canonical 
pathways [60].  
The negative regulation of Wnt signalling pathway can occur at both extracellular 
and intracellular level. Secreted Wnt antagonists can block the Wnt signalling 
pathways through different mechanisms. Thus, they can be divided into two 
functional categories. Members of secreted frizzled related protein (sFRPs) class, 
which includes the sFRPs family, Wnt inhibitory factor (WIF-1) and Cerberus, bind 
with Wnts ligands directly, thereby preventing Wnts binding with receptors to block 
both canonical Wnt and non-canonical signalling pathway. Members of Dickkopf 
family (Dkks) class, which includes Dkks family, sclerostin and Krmen 1/2(Krm1/2), 
can inhibit co-receptor LRP5/6 complex to further block the canonical Wnt 
signalling pathway [64-65].  
Recent finding revealed that sclerostin, a secreted protein in humans that encoded by 
the SOST gene, could interact with extracellular Wnts co-receptors LRP5/6 domains 
to competitively prevent the various Wnts binding with co-receptors. Sclerostin was 
initially characterized as a BMP antagonist, based primarily on its homology to the 
DAN family of cystine knot-containing proteins [4, 66]. Thus, in theory, sFRPs class 
antagonists could inhibit both canonical and non-canonical signalling pathways, 
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whereas those of DKKs and sclerostin class specially inhibit the canonical Wnt 
signalling pathway.  
 
Figure 3-4. Functional extracellular and intracellular Wnt antagonists [67]. Extracellular 
antagonists include sclerostin that bind and inhibit LRP5/6, WIFs that bind Wnt ligands, and 
SFRPs that bind Frz and competively inhibit the LRP interaction with Fzd. Krm and Dkks 
facilitate LRP inactivation through internalization of the receptor. The intracellular inhibitors 
include GSK3β/Axin/APC complex that inhibit β-catenin translocation to the nucleus and 
Chibby that blocks β-catenin association with its transcription factors in the nucleus. 
 
Intracellular inhibitors include the GSK3β/Axin/APC complex and Chibby (Fig. 3-
4). GSK3β/Axin/APC complex inhibit β-catenin translocation into the nucleus. 
Chibby competes with Tcf/Lef transcription factors, leading to the blockage of 
canonical Wnt signalling [68]. The antagonist regulation of Wnt cascade is critical in 
a variety of disease processes, and therefore, has tremendous potential in therapeutic 
regimens. 
Regulation of the canonical Wnt signalling pathway in tooth development  
The canonical Wnt signalling is dynamically active in tooth-forming regions at 
multiple stages of tooth development, and plays multiple critical roles in these events 
[4, 69].  
Multiple Wnt genes are expressed at the initiation of mouse tooth development. 
These include Wnt10b, which is expressed specifically in the molar and incisor 
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dental epithelial thickenings. Wnt4, Wnt6 and Fz6 are observed in dental epithelium. 
At the early cap stage, Lef1, Wnt3, Wnt6, Wnt10b, and Fz6 are detected in the 
primary enamel knot, a transient signalling centre in the developing tooth. While 
Wnt5a and Fz1 show strong expression in the dental papilla mesenchyme [70].  
β-catenin is a critical member of canonical Wnt signalling pathway, through post 
translation modifications that inhibits its cytoplasmic degradation as the result of the 
upstream activation of the pathway [71-72]. β-catenin expression was found in 
developing tooth bud, enamel knot and secondary enamel knot. Wnt 10a was 
expressed in secretory odontablasts and is an upstream regulatory molecule for 
dentin sialophosphoprotein (Dspp) which is a tooth-specific non-collagenous matrix 
protein regulating dentin mineralization. Overexpression of Wnt3 in dental 
epithelium resulted in the loss of ameloblasts and a reduction of enamel in post-natal 
incisors, suggesting that the canonical Wnt signalling might play a role in enamel 
formation [73]. Liu etc. demonstrated that constitutively mutation of β-catenin in 
dental epithelium caused formation of large, misshapen tooth buds and ectopic teeth. 
In addition, inducible Dkk1 expression after the bud stage caused formation of 
blunted molar cusps and loss of restricted ectodin expression. These data 
demonstrated that canonical Wnt signalling is essential both for patterning tooth 
development in the dental lamina, and for controlling the shape of individual teeth 
[4]. Together, these results indicate that activation of the mesenchymal odontogenic 
program during early tooth development requires concerted actions of Bmp, Fgf and 
Wnt signalling from the presumptive dental epithelium to the mesenchyme [74]. 
In postnatal stage, it is noted that HERS is important for tooth root formation. 
Enhanced canonical Wnt signalling is expressed in the HERS [62]. It is known that 
cementum formation is sensitive to intra/extracellular phosphate/pyrophosphate 
distribution, and treatment of inorganic phosphate in immortalized mouse 
cementoblasts alters the expression of several Wnt pathway genes. Expression of the 
secreted canonical Wnt signalling Sfrp4 inhibitor is enhanced, while expression of 
the Wif1 and Dkk3 inhibitors and the Wnt10b and Wnt4 ligands is diminished [75]. 
Sfrp4 has been identified as a potential phosphaton in a putative circulating regulator 
of phosphate concentration [66]. Analysis of these data suggests that Wnt signalling 
may be involved in cementum formation. 
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Recently, several research papers concern the role of canonical Wnt signalling in 
tooth root formation. An OC-Cre;Catnb(lox(ex3)/+) mouse model was created to 
obtain persistent stabilization of β-catenin in the dental mesenchyme; and the results 
demonstrated that malformed teeth were characterized by aberrantly formed dentin 
and short molars roots covered with the excessively formed cellular cementum [76]. 
Furthermore, more details were found in OC-Cre;Catnb(lox(ex3)/+) mouse model 
that dental papilla cells were prematurely differentiated and had a disorganized 
arrangement at the beginning of root formation in mutant molars. In addition, Dkk2 
was upregulated in the cementum of mutant mice. These results suggest that 
temporospatial regulation of canonical Wnt signalling plays an important role in cell 
differentiation and matrix formation during root and cementum formation [77].  
To further understand the role of canonical Wnt signalling in the dento-alveolar 
complex formation, Col1a1-cre mediated conditional activation of β-catenin was 
generated in osteoblasts and odontoblasts. Mutant mice showed that tooth formation 
and eruption was disturbed with hypoplastic cementum and periodontal ligament. 
While cementum matrix proteins were decreased, bone matrix proteins were 
increased in the cementum and alveolar bone of mutant mice [78]. Zhang etc. 
conditionally knocked out beta-catenin gene (Ctnnb1) within developing 
odontoblasts and cementoblasts during the development of tooth roots, and observed 
rootless molars as well as incomplete incisors. The formation of dentin and 
periodontal tissues were greatly hampered. This study provides strong in vivo 
evidence to confirm that canonical Wnt signalling is functionally significant to root 
odontogenesis and cementogenesis during the tooth root development [79]. All these 
recent findings indicate that local modulation of canonical Wnt signalling has 
therapeutic potential to improve the regeneration of dentin and periodontium. 
Role of Axin2 in tooth development  
Axin, body axis development suppressor gene (axis inhibitor), was first cloned from 
the mutant mice and encode two axis protein members of Axin1 and Axin2 in 
vertebrates [80]. Axin2, also known as Conductin or Axil, is a negative Wnt 
signalling pathway regulatory factor and the direct target gene of canonical Wnt 
signalling pathway [81]. Axin2 is also a homolog of Axin1, baring 45% amino acid 
sequence with Axin. Although they have similar biological characteristics, they 
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function completely differently in the organogenesis. Axin1 is expressed in every 
organ in the embryonic development, while Axin2 expression is concentrated in 
specific organs, and its expression must be activated by Wnt signalling [82-84].  
Axin2 has a series of protein binding sites as a structure protein, and can combine 
with many members of the Wnt signalling pathway, such as APC, GSK-3β, β-catenin 
and Dvl protein. Then they can form a protein complex that promote the 
phosphorylation and degradation of intracellular -catenin to maintain at a low level. 
Therefore, Axin2 plays two functions in the canonical Wnt signalling pathway. First, 
similar to Axin1, it is a negative regulation of Wnt signalling pathway through the 
formation of complex induce degradation of the cytoplasmic -catenin. Secondly, 
Axin2 is a direct target gene of the canonical Wnt signalling pathway and its 
expression level directly reflects the Wnt signalling pathway [85]. Hence, this forms 
a negative feedback loop. 
In humans, loss of Wnt10a or Axin2 can cause tooth agenesis [86-87]. The 
expression of canonical Wnt signalling is concentrated in dental mesenchyme in the 
early mouse tooth development, but Axin2, as the reporter gene of canonical Wnt 
signalling pathway, can be observed in both epithelium and mesenchyme in the 
developing tooth [88]. At the lamina and bud stage of molar, Axin2 is observed in 
both the epithelium and underlying mesenchyme. At the cap and bell stage, Axin2 
was strongly expressed in the primary and second enamel knots respectively. Weak 
Axin2 expression can be detected in the odontoblasts, which resembles the 
localization of nuclear β-catenin. High levels of Axin2 expression were found in 
odontoblasts, dental pulp and surrounding the developing root in the postnatal teeth, 
while Axin2 was lost in the crown odontoblasts. During the late stages of 
cementogenesis, Axin2 continues to express in HERS and developing root in high 
levels. Between the roots, Axin2 was also highly expressed forming a V-shape [89]. 
High level of canonical Wnt signalling pathway was also noted in the developing 
molar roots in accordance with Axin2 expression during root formation (Fig. 3-5). 
All indicates that canonical Wnt signalling has a new role in controlling root 
development in late stages of postnatal tooth development in addition to an important 
role in embryonic tooth development.  
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Figure 3-5. The expression pattern during tooth crown and root formation [89]. 
Diagrammatical representation of Axin2 expression (blue) was identified both mesenchyme 
and epithelium at the different stages of tooth formation and postnatal teeth.  
3.2 CURRENT PROGRESS OF PERIODONTAL REGENERATION 
3.2.1 The structure of cementum in periodontium   
Normal tooth cementum is a bone-like mineralized tissue with collagen fibrils, as it 
is a key organic component presented on the surface of root dentin. It also can 
provide the “bridge” to support the periodontal ligament between the root dentin and 
surrounding alveolar bone. The periodontium structures are cementum, periodontal 
ligament and alveolar bone as shown in Figure 3-6. 
Cementum is secreted by the cementoblasts, which are the cementum-forming cells 
develop from undifferentiated dental follicle mesenchymal cells. The inorganic 
portion of cementum is hydroxylapatite (HAp) crystals (Ca10(PO4)6). The organic 
part is composed primarily of collagen, protein polysaccharides and water. The 
periodontal ligament is made up of Sharpey's fibres inserted in the cementum and 
alveolar bone, which attaches the tooth to the alveolus. Cementum is avascular and 
therefore, cannot spontaneously be regenerated [90].  
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Figure 3-6. The natural structure of tooth with two anatomical parts: crown and tooth root 
[90]. The crown of a tooth is the part which is covered with enamel and this is usually 
visible in the mouth. The root includes periodontal ligament, alveolar bone and cementum 
and tooth root dentin. 
Collagen fibres in the cementum can be divided into two different kinds: intrinsic 
fibres (fibres arranged in parallel with cementum surface), and extrinsic fibres (fibres 
embedded into the ends of the primary fibres). There are two kinds of cementum 
formed: acellular and cellular. Acellular cementum, also called acellular extrinsic 
fibre cementum or primary cementum, is the first formed cementum during tooth 
development and is located on the coronal half and mid portion of the tooth root.  
The acellular layer of cementum is the living tissue that does not have cells 
incorporated into its structure. Whereas, many of the cementoblasts become 
entrapped by the cellular cementum they produce, becoming cementocytes. 
Moreover, cellular cementum is found more frequently on the apical and 
interradicular half [91]. Additionally, there are many noncollagenous components in 
cementum, such as bone sialoprotein, osteocalcin and osteopontin; these 
glycoproteins impart the cohesion and structural integrity to the cementum [92-93]. 
Recently, cementum-derived attachment protein (CAP), and human 
cementoblastoma-derived protein cementum protein 1 (CEMP 1) have been regarded 
as specific factors to the cementoblast differentiation and cementum matrix [94]. 
To date, the cellular origin is still controversial for cementum regarding the cell 
source, which is from epithelial or mesenchymal. This disagreement is perhaps partly 
due to the poor understanding of the events during the initiation and development of 
tooth root. It is clear that bone tissues are secreted by osteoblasts that are derived 
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from mesenchymal progenitor cells, but it is still unclear with respect of the cell 
source for cementum and whether cellular and acellular cementum are from the same 
progenitor cells [90, 95]. One theory is that cementoblasts are derived from the 
mesenchymal progenitor cells/dental follicle cells and directly differentiate into both 
cellular and acellular cementum by invading the epithelial HERS [95]. Other 
speculation suggests that epithelia HERS cells formed cementoblasts through the 
epithelium-mesenchymal transformation process [96]. However, these proposals are 
not based on gain-of-function and loss-of-function research methodology. Recently, 
Feng’s lab demonstrated that the cell source for cellular cementum is mesenchymal 
periodontal ligament progenitor cells in which osterix (OSX), plays a vital role 
during cementogenisis [97]. In their study, they carried out gain- and loss-of-function 
methodologies to study the cellular cementum origin targeting OSX. Using the OSX 
over-expression mice model with a Collagen 1A promoter, they found that in an 
increase in cementum mass. On the other hand, the deletion of OSX gene can reduce 
the cementocyte numbers and morphology with a significant reduction in 
mineralization rate. Taken together, these data support the idea that derivation of 
cellular cementum may originate from mesenchymal dental follicle cells [97]. 
3.2.2 Cell sheets techniques in periodontal tissue regeneration   
The periodontal tissue regeneration is a complicated functional replacement of the 
tooth supporting structures, including the periodontal ligament, cementum and 
alveolar bone to maintain the teeth in the jaw. Due to periodontal diseases lead to the 
destruction of periodontal tissues, which affect 30-40% of the population. It is of 
great importance to reconstitute the periodontium complex including alveolar bone, 
PDL and root cementum [98]. In the process of periodontal tissue regeneration, one 
of the most critical and difficult components is cementum regeneration. Ideally, the 
newly formed periodontal fibres are inserted into the regenerated cementum to attach 
with the root surface and new alveolar bone. Tissue engineering provides a new 
method based on the molecular and cellular biology for regeneration of 
periodontal/cementum which is a complicated biological process in itself [99].  
Tissue engineering was emerged in 1990s involving three elements: signalling 
molecules, scaffold and stem cells. In periodontal regenerative therapy, researchers 
are trying to establish new treatments to accelerate the regeneration of periodontal 
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tissues by combining typical human recombinant cytokines and human mesenchymal 
stem cells into hard-tissue forming cells. Along with the recent progress in tissue 
engineering, cell sheet engineering have been developed as the foundations for 
periodontal regeneration, including alveolar bone, cementum and periodontal 
ligament [7]. The cell sheet technique was invented by Okano et al. using a surface-
grafted temperature-responsive polymer called poly N-isopropylacylamide 
(PIPAAm). PIPAAm is fully hydrated at temperatures lower than 32
o
C with an 
extended-chain conformation; however, PIPPAAm is dehydrated and compacted 
when temperature exceed 32
o
C. PIPPAAm was then engrafted into atemperature-
responsive dish to allow intact cells to be harvested at lower temperature [7]. It has 
been reported that cell sheets can be fabricated from different types of cells including 
fibroblasts, hepatocytes, endothelial cells, macrophages and retinal pigmented 
epithelial cells. Some of these cell sheets have been applied in vivo and have 
demonstrated remarkable results [100-102]. Regarding periodontal regeneration, 
periodontal ligament cells have shown the potential ability to regenerate 
periodontium by application of the cell sheet technique in previous studies in beagle 
dog [20]. Dehiscence defects were healed with bone, periodontal ligament and 
cementum formation in the experimental group in which periodontal ligament cell 
sheets were engrafted [20]. Following the successful research in beagle dogs, newly-
formed cementum-like hard tissues were regenerated on the dentin surfaces in the 
transplanted periodontal ligament cells-dentin block constructs in athymic rats [103-
104]. Based on these studies above, three-layered osteogenic medium cultured 
periodontal ligament cell sheet were transplanted autologously onto dental root 
surface in canine periodontal defect model. The bone defect was filled with beta-
tricalcium phosphate (β-TCP). The results showed that cell sheet transplantation 
regenerated more new bone and cementum connective tissues and well-organized 
collagen fibres when compared to the non-cell sheet control groups [105]. Another 
study investigated the regenerative potential of different cell sheets derived from 
periodontium (gingival connective tissue, alveolar bone and periodontal ligament) 
supported by a calcium phosphate coated melt electrospun polycaprolactone (CaP-
PCL) scaffold and then were transplanted in an athymic rat periodontal defect model. 
It was noted that hPDLCs and alveolar osteoblasts cell sheet with a CaP-PCL 
scaffold resulted in significant periodontal attachment formation. While the gingival 
cell sheets did not promote periodontal regeneration on the root surface and inhibited 
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bone formation within the CaP-PCL scaffold [106-107]. Furthermore, PDL cell 
sheets were placed on the electrospun membrane and osteoblasts were cultured in the 
bone compartment. Then the cell-seeded biphasic scaffolds were placed onto a dentin 
block and implanted for 8 weeks in an athymic rat subcutaneous model. Data 
demonstrated that a thin mineralized cementum-like tissue was deposited on the 
dentin surface for the scaffolds incorporating the multiple PDL cell sheets, as 
observed by H&E and Azan staining [108]. These results suggest that periodontal 
ligament cells possess multiple differentiation properties, which can assist 
regeneration of injured periodontal tissues using cell sheet grafting technique. 
3.2.3 Stem cells as powerful therapeutics for periodontal regeneration 
Since stem cells, also known as precursor cells, have been considered as attractive 
candidates for tissue regeneration, due to they have the capability of self-renewal and 
multi-lineage differentiation. Based on the varying potentials, stem cells can be 
divided into two categories: embryonic stem cells and adult stem cells [109]. Due to 
the ethics considerations and regulations, adult crest-derived mesenchymal stem 
cells, such as periodontal ligament stem cells (PDLSCs) [110], dental follicle 
precursor cells (DFPCs) [111] and bone marrow mesenchyme stem cells (BMMSCs) 
[112], have been identified as more appropriate candidates for cementum 
regeneration. PDLSCs, which are isolated from the periodontal ligament of human 
third molars, are capable of differentiating into cementoblast-like cells in vitro, and 
show the ability to produce cementum-like tissues in vivo [113]. DFPCs have also 
been isolated from human third molars, but there is no cementum formation observed 
in transplants in vivo. The expression of cementum specific makers, however, such as 
CAP and CP-23, has been detected in the cultured DFPCs after incubation with 
human recombinant protein of rhBMP2 and rhBMP7 or enamel matrix derivatives 
(EMD) for 24 hours [114]. Subsequently, other dental mesenchymal stem cells were 
isolated from human exfoliated deciduous teeth (SHED) and noted to form bone and 
dentin in vivo [115]. Stem cells from apical papilla of human teeth (SCAP) have aslo 
been shown to form dentin tissues in immunocompromised mice and generate root-
periodontal complex after transplantation with periodontal ligament cells in minipigs 
[116-117]. The dental follicle progenitor cells can be obtained from human third 
molar and have been proven to differentiate into osteoblasts/cementoblasts in vitro; 
they can generate PDL-like tissues during in vivo implantation [111]. These data 
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demonstrated that dental mesenchymal stem cells are appropriate cell sources for 
periodontal regeneration application.  
Non-dental mesenchyme stem cells, BMMSCs also have the potential to produce the 
cementum-like tissue, when BMMSCs were loaded around the fixtures of the porous 
poly-DL-Lactide-co-Glycolide scaffolds with a hollow root-shape. Periodontal-like 
tissues including cementum, alveolar bone and periodontal ligament can be detected 
around the implants after one-month implantation in goats [118]. Apart from 
BMSCs, adipose-derived stem cells (ASCs) can generate new PDL-like and alveolar 
bone-like structures, when transplantation occurs in a rat and canine periodontal 
defect models. Although current evidence suggests that ASCs can be induced to 
periodontal tissues, the mechanism by which these stem cells can be directed towards 
strict periodontal cell differentiation remains uncertain [119]. These results, 
therefore, suggest that both dental and non-dental derived stem cells are able to be 
applied in cementum/periodontal regeneration.  
3.3 THE CONCEPT OF PERIODONTAL TISSUE ENGINEERING  
The current tissue engineering principles and strategies should be applied to 
accelerate restoration of periodontal complex. Recently, Chen etc. addressed the 
concept of periodontal tissue engineering with three key factors: biological cues, 
stem cells or progenitor cells and suitable biomaterials. The bioactive cues can be 
absorbed or encapsulated in the biomaterials scaffolds to implant at the periodontal 
defect, which can lead to cell homing/recruitment from healthy tissues to the defect. 
The homed cells will proliferate and differentiate into fibroblasts, cementoblasts and 
osteoblasts. Subsequently, differentiated tissues will be achieved in the periodontal 
defects including periodontal ligament, alveolar bone and cementum. In this regard, 
periodontal defects can likely be reconstructed by utilizing bioactive cues, biological 
active proteins, biopolymers/bioscaffolds, and/or patient-derived regenerative ‘tools’ 
(Fig. 3-7). Meanwhile, more efforts are still required to optimize the cell-delivery 
materials and strategies to accelerate the periodontal tissue regeneration process. 
Further development of periodontal bioengineering requires the incorporation of 
multiple areas covering biology, engineering, dentistry, biomaterials and the dentists 
who can access the fundamental knowledge into clinical application.   
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Figure 3-7. Schematic illustration of the periodontal regeneration using an endogenous 
regenerative approach [14]. This approach requires the partnership of bioactive cues, 
biomaterials and/or patient-derived progenitor cells and transplantation into the periodontal 
defect. The cells proliferate and differentiate into specific periodontal fibroblasts, osteoblasts 
and cementoblasts which can differentiate into periodontal ligament, alveolar bone and 
cementum finally over time. NB, new bone; NPDL, new periodontal ligament; PDL, 
periodontal ligament; NC, new cementum.  
Clinically, several procedures have been attempted to regenerate periodontal tissues, 
including bone grafting (autograft, allograft and xenograft), conventional flap 
surgery, guided tissue/bone  regeneration (GTR/GBR) and the use of various growth 
factors/host modulators (Emdogain and parathyroid hormone) [120-121]. GTR/GBR 
is a technique that involves the placement of a barrier membrane at the periodontal 
defect to aid the repair of periodontal tissues. As mentioned above, the proper growth 
factors (GF), a stem cell graft and scaffold for delivering and retaining cells are 
required for a promising alterative of periodontal regeneration [122-124]. The role of 
the scaffold is to provide an environment for guiding or assisting the regeneration in 
vivo and in vitro. Subsequently, the scaffolds need to be designed with suitable 
surfaces for cell adheshion and differentiation, and then be optimized to ensure 
adequate mechanical integrity and osteoconductive properties [15].  Therefore, it is 
the tissue engineering that could provide a variety of laboratory products (such as 
stem cells, material niches, tissue constructs or engineered tissues) for clinical 
therapies and transplantation. 
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3.3.1 Mesoporous bioactive glass 
Bioactive glass, due to their versatile properties of osteoconductivity, composition, 
and good degradation rate have been very attractive materials for bone regeneration. 
The first generation of bioactive glass was synthesized by Hench named with 45S5
®
 
bioactive glass, belonging to SiO2-Na2O-CaO-P2O5 system using the traditional 
sintering melt method; it was found that 45S5 glass was able to bond with closely 
with bone tissues [125-126]. Since then, many other ions, such as silicate, borate and 
phosphate glasses, have been proposed by researchers for bone tissue engineering. 
However, 45S5 glass was only limited formed as powders, particles and dense bulk 
of large shapes and sizes without microporous structure. On the other hand, 
mesoporous materials possess significantly ordered mesoporous structure pore size 
within 2-50 nm and well-defined hydrophobic/hydrophilic surface; however, 
mesorporous materials have lower bioactivity [127].  
Thus, to overcome the problems related to poor bioactivity of pure-silica mesoporous 
biomaterials and conventional bioactive glass without mesoporous structure, it is of 
great importance to synthesize mesoporous bioactive glass (MBG) that combine 
efficient mesoporous structure and excellent bioactivity. The first MBG was prepared 
by the combination of sol-gel method and it was found that MBG possess more 
optimal surface area, pore volume and excellent in vitro cytocompatibility compared 
to the conventional non-mesoporous bioactive glass (NBG) [128]. Currently, based 
on the different preparation methods, MBG materials can be synthesized in different 
forms: particles, powders, fibres and scaffolds [129-130]. Among them, MBG three-
dimensional porous scaffolds have been attractive for bone tissue engineering, due to 
their highly interconnective pore structure and optimal porosity [129]. A significant 
advantage of MBG is that it possesses superior apatite-mineralization ability in 
biological solution.  
MBG has been regarded as a potential bioactive bone regeneration material owing to 
its superior bioactive behaviour. Further in vitro and in vivo osteogenesis has been 
studied in the past several years. Wu et al. reported a new facile method to prepare 
hierarchical and multi-functional MBG scaffolds that demonstrated excellent pore 
size, mechanical strength and osteoinductive ability for bone regeneration application 
[131]. They further confirmed that the incorporation of MBG particles onto PLGA 
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enhanced the proliferation and relative ALP activity of human osteoblasts. In 
addition, they incorporated Fe, Sr, Zr and B ions into MBG scaffolds which also 
enhance cell proliferation and osteogenic differentiation [129]. The presence of Sr 
significantly enhanced oesteogenesis/cementogenesis-related gene expression (such 
as ALP, CEMP1 and CAP) of human periodontal ligament cells [132]. It was also 
reported that the ionic product from nanoscale bioactive glass can not only increase 
osteogenic markers, thereby enhancing proliferation, cell attachment and 
mineralization, but also enhance cementoblast viability, proliferation and 
mitochondrial activity [133]. Furthermore, Wu et al. also prepared MBG/silk 
scaffolds and found that MBG/silk scaffolds could enhance expression of Collagen I 
and new bone formation after transplantation into a rat calvarial defect [134]. 
Recently, three-dimensional printed MBG scaffolds were placed into the defects of 
rat femur. After four weeks of implantation, MBG scaffolds induced a great amount 
of new bone ingrowths in the defects. The results further indicate that MBG has 
excellent in vivo osteoinduction for potential bone repair application [135]. These 
results demonstrated that MBG is a new bioactive material, which has significant 
potential to improve bioactivity and osteoconduncivity in vitro and in vivo for bone 
tissue regeneration application.  
It is reasonable to suggest that bioactive glass could have a similar effect on 
periodontal ligament cells osteogenic/cementogenic differentiation capability. It is 
also reasonable to hypothesize that an increase in osteogenic proliferation of hPDLCs 
in vitro could response by the presence of MBG. In this study, it has been 
investigated involving the potential application for MBG scaffolds during 
osteogenic/cementogenic differentiation for hPDLCs. 
3.3.2 Bioceramics: beta-tricalcium phosphate (β-TCP) 
In natural bone, the three main components are calcium phosphate, water and 
collagen (predominantly type I collagen), together with other organic materials in 
smaller quantities, such as non-collagenous proteins, polysaccharides, and lipids 
[136].  Calcium phosphate in bone is in the form of crystallized hydroxyapatite (HA) 
and amorphous calcium phosphate (ACP). Bioceramics or mineral-based scaffolds 
have long been recognized as potent osteoconductive materials for regenerative hard 
tissues, such as bone and dentin as they can possess a crystalline structure [137]. 
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There are several variables influencing  the efficacy of bioceramics, such as chemical 
composition, surface roughness, hydrophilicity and topography of surface of 
ceramics, which would directly influence their cells response, osteoconductivity, 
vascularisation, osseointegration and material resorption [138].  The most popular 
material is β-TCP ceramics which possess high biocompatibility, osteoinduction and 
biodegradability [139]. β-TCP biodegrades more readily, thereby gradually being 
resorbed and replaced by host tissues in the body [140].   
While β-TCP has been well established as a drug carrier for bone regeneration, 
recent data suggested that β-TCP alone or combining with other materials, have vital 
role as a cell carrier for periodontal regeneration [139]. It was reported that a dentin-
pulp complex was successfully constructed, when porcine dental papilla cells were 
seeded on a β-TCP scaffold and transplanted into nude mice [141]. Consequently, 
when human PDLCs were seeded into β-TCP porous scaffold, vascular tissue 
ingrowth, differentiation of hPDLCS into osteoblasts and cementoblasts were 
reconstructed in vivo [142]. It was also reported that akernanite ceramics can 
stimulate cell attachment, proliferation and osteogenic differentiation of hPDLCs 
compared to that of β-TCP ceramics [143]. Similarly, when seeding dog PDLCs on a 
nano-HA/collagen/PLA scaffold, it showed significant enhancement of cell 
attachment, proliferation and osteogenic differentiation compared to conventional β-
TCP [144]. Although β-TCP bioceramics are generally biodegradable and 
biocompatible, they are still far from optimal for stimulating the 
osteogenic/periodontal differentiation of stem cells to achieve further shorten healing 
time of tissue defects. In the past several years, strontium modified β-TCP 
bioceramics enhanced cell viability and differentiation for osteoblast-like cells with 
improved bioactivity have been prepared for bone regeneration application [145]. 
This inspired us that bioactive ions modification to β-TCP bioceramics may be a 
viable method to stimulate differentiation of mesenchyme stem cells for better tissue 
regeneration. In this research, whether β-TCP is another class of suitable biomaterial 
for cementum regeneration applications was investigated. 
3.3.3 Cell and growth factors delivery through biomaterials 
For periodontal tissue engineering, solid materials should be designed to posess pore 
size that allows the cellular ingrowth inside of scaffolds as periodontium is not only 
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made up of bone tissues. The cell-scaffold constructs stimulate the formation of 
reparative tissue while maintaining adequate integrity following the implantation 
[119]. Another clinical challenge is the neogenesis of osseous and ligamentous 
interfacial structures where the three-dimension shape of the natural tissues have to 
be achieved. Interconnecting porosity facilitates nutrient supply into central regions 
of engineered transplants, thereby preventing adverse effects such as tissue necrosis.  
Consequently, it is still under investigation for the optimal geometries and 
dimensions of tissue-engineered solid scaffolds for  periodontal applications [15]. 
Recently, it was shown that the fabrication of composite hybrid polymeric scaffolds 
(Poly-ε-caprolactone/poly (glycolic acid)-PCL/PGA) for gene modified human cells 
transplantation can form dentin-ligament-bone complexes [146]. Furthermore, a 
fibre-guiding scaffold was also developed that fit complex anatomical defects to 
guide the new oriented ligament fibres in vivo, due to periodontal bioengineering 
requiring functional restoration of complex topologies and tissue integration. The 
results showed that cell delivery with hybrid scaffolds lead to a predicted fibre 
orientation and better control of tissue infiltration compared to the conventional 
transplantation complex [147]. More recently, biophasic scaffolds were developed 
made of a fused deposition modelling bone components (β-TCP) and a micro-fibrous 
periodontal component (PCL) to provide simultaneous delivery for PDLCs and 
osteoblasts to form an alveolar bone/PDL complex. The in vitro results showed β-
TCP bone component supported the cell growth and PCL periodontal component 
allowed harvesting multiple cell sheets. It is an ectopic assay but it would fulfil some 
of the principles of GTR allowing enough space and stabilization for successful 
periodontal regeneration [148]. Thus, it is noted that cell-based research in 
periodontal tissue engineering has started to focus on designing and developing 
various advanced physical and geometric biomaterials. In addition, the increasing 
degree of sophistication will require a better understanding of how cells interconnect 
with the biomaterials and how the cell signalling pathways process this procedure to 
initiate the biological responses.   
To date, the use of bone grafting materials, exogenous growth factors and cell-based 
approaches have been employed easily in clinical practise to induce 
promotion/augmentation of self-healing capacity for the treatment of periodontitis. It 
is well known that the application of growth factors of platelet-rich growth factor 
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(PDGF), BMPs, fibroblast growth factors (FGFs) and transforming growth factors β 
(TGF-β) for stimulating robust and self-regenerative localized mechanisms have 
been of increasing interest in periodontal regeneration [149-150]. These growth 
factors (GFs) have been proven to stimulate the systematic cellular signalling 
responses to regulate critical activities, such as cell survival, proliferation and 
mineralization that may lead to functional tissue regeneration. Growth factors also 
can degrade the extracellular matrix (ECM) proteins to orchestrate intracellular 
signalling transduction by binding with the extracellular domain of a targeted growth 
factor receptor [150-151]. However, there are still a few known issues associated 
with GF-based therapeutics that should be considered, such as the short half-lives in 
vivo, their relatively large size, slow penetration, and potential denaturation during 
manipulation. Ideally, the delivery of GFs to the periodontium should be localized, 
following specific and distinct kinetics in order to mimic the healing process in the 
injured periodontal tissues [15, 119]. To address this problem, the GFs require the 
carriers and suitable delivery systems derived from diverse biomaterials to not only 
act as a cell vehicle but also as a carrier controlling the release of GFs during tissue 
regeneration process. Many of them, by means of combination of growth factors with 
biomaterials, can provide a well-controlled release into a microenvironment to yield 
desirable concentrations over time. Most frequently used biomaterials for tissue 
engineering are polylactic acid (PLA), β-TCP and natural polymers such as collagen, 
gelatine and dextran [14, 18, 151]. Given all these facts, previous findings and efforts 
using growth factors presents only the beginning the development of an ideal system 
for periodontal regeneration. In this study, I am trying to investigate the cellular 
signalling activation in the biomaterials delivery system without growth factors for 
periodontal regeneration.   
3.3.4 The canonical Wnt signalling in osteogenesis and bone regeneration 
In recent years, the role of canonical Wnt signalling in bone biology has gained 
considerable attention. This part of review will underline the significance of 
therapeutic potential canonical Wnt signalling in bone regeneration, thus inspired us 
to investigate the role of canonical Wnt pathway during periodontal regeneration 
application in this study. Given the numerous findings demonstrated that canonical 
Wnt signalling regulates osteogenesis as shown in animal studies and genetic 
disorders in human. Besides, there are multiple levels of regulators, which modulate 
 Chapter 3: Literature Review 35 
the osteogenesis, such as Wnt receptors, secreted antagonists and intracellular 
mediators. Thus inducing this pathway has arisen as an attractive therapeutic target to 
promote bone formation for treating osteogenic disorders. 
The canonical Wnt signalling stimulates bone formation 
Homozygous mutations of Sost is associated with a progressive increase in bone 
mass, hyperostotic skeleton and increased bone mineral density in autosomal 
recessive diseases Sclerostosis and Van Buchen disease[152]. Sclerostin is directly 
involved in the regulation of osteoblastic differentiation through the antagonism of 
the Wnt signalling pathway Sost knockout mice have a high bone mass phenotype 
characterized by marked increases in bone mineral density, bone volume, bone 
formation, and bone strength [153]. Overexpression of Lrp5 leads to increased bone 
mass in mice, while knockout mutations reduce bone mineral density from a defect 
in osteoblast proliferation [154]. Furthermore, conditional deletion of β-catenin 
results in increased bone mass in mice, leading to impaired mineralization secondary 
to a deficiency of terminally differentiated osteoblasts in mice [155].  
The Axin/GSK3β/APC complex has been shown to play a role in osteogenesis. Axin 
2 knockout mice present with increased osteoblast proliferation, craniosynostosis, 
increased chondrocyte differentiation, reduced limb length, and increased bone mass 
phenotypes [156]. GSK3β also regulates osteogenesis. Heterozygous Gsk3β alleles 
mice exhibit increased bone mass and lithium, as GSK3β inhibitors is able to 
increase bone density and enhance osteoblast differentiation [157] . 
Target extracellular Wnt signalling antagonist of sclerostin for bone regeneration 
Inhibition of extracellular Wnt antagonists with monoclonal antibodies has been a 
popular approach to modify the Wnt signalling pathway and promote bone 
regeneration. One highly promising endeavour is to target sclerostin using 
humanized neutralized sclerostin antibodies. Sclerostin is a glycoprotein with a 
molecular mass of 24 kDa, which is the product of the SOST gene expressed almost 
exclusively in osteocytes. It is produced by osteocytes to locally regulate bone 
formation and is vital for enabling bone responding to mechanical loading [158]. 
Sclerostin binds to the extracellular domain of Wnt receptors LRP5/6, preventing the 
binding of various Wnt ligands to these co-receptors and inhibiting canonical Wnt 
signalling. Sclerostin can, therefore, negatively regulate osteoblastic bone formation 
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[10, 159]. Thus, neutralized sclerostin antibody (Scl-Ab) could activate the canonical 
Wnt signalling to promote bone regeneration (Fig. 3-8 and Table 3-1). 
The most recent study has investigated effects of sclerostin antibody on fracture 
healing in femur defects models [11]. In a rat closed femur fracture model and a 
nonhuman primate fibular osteotomy model, sclerostin antibody was administrated 
subcutaneously at  25 mg/kg twice per week for 7 weeks or 30 mg/kg every 2 weeks 
for 10 weeks respectively, to investigate the effects of sclerostin antibody on fracture 
healing. The results showed that sclerostin antibody could significantly increase bone 
mass and strength at the cortical and trabecular fracture sites [11, 160]. In a rat closed 
femur fracture model, 4 weeks of treatment with sclerostin antibody twice weekly at 
25 mg/kg resulted in improved callus density, increased maximum load and stiffness 
and increased bone strength parameters [161]. In a 6 mm femoral defect model for 
Lewis rats, 12 weeks of continuous administration and treatment also resulted in 
bone healing with pronounced radiographic healing and bone volume compared to 
non-treatment group [11].  
 
Figure 3-8. Mechanism of Scl-Ab and lithium in Wnt signalling pathway [162]. In the 
presence of sclerostin, the ligands cannot bind their receptors to activate the Wnt signalling. 
The inhibitory effects of sclerostin proteins can be neutralized by Scl-Ab, thus activating the 
Wnt signalling pathway downstream. GSK3β normally targets β-catenin for degradation by 
phosphorylation. However, lithium can inhibit the GSK3β activity, thus allowing β-catenin 
to accumulate in the cytoplasm and the nucleus expressing the target genes. Scl-Ab, 
sclerostin antibody; GSK3β, glycogen synthase kinase 3β. 
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Studies have showed that subcutaneous injection of neutralized sclerostin antibodies 
markedly increased bone formation in ovariectomised rats after 5 weeks of treatment 
[163-164]. In a 3-mm circular femoral defect model in Sprague-Dawley 
ovariectomised rats, sclerostin antibody was administered twice weekly for 3 weeks, 
sclerostin antibody significantly improved both intramembranous and endochondral 
bone formation and enhancing bone formation and bone volume [165-166]. 
Recently, in a phase I clinical trial, a single dose injection of anti-sclerostin antibody 
given to post-menopausal women increased the bone mineral density of the lumbar 
spine and increased production of collagen type I over 85-day study period [167].  
Ligature-induced experimental periodontitis (EP) generated in alveolar bone defects. 
Following 4 weeks of disease induction, Scl-Ab were systemically delivered twice 
weekly for up to 6 wks to determine the ability of Scl-Ab to regenerate bone around 
tooth-supporting osseous defects. 6 weeks of Scl-Ab significantly improved 
maxillary bone healing, indicating Scl-Ab treatment restored alveolar bone mass loss 
in a preclinical animal model of periodontitis [168]. The current knowledge 
presented by different research groups already identified an important role of 
sclerostin antibody in improving bone formation in fracture healing models; 
however, not few studies investigate the effect of sclerostin antibody in periodontal 
defect model.  
Target intracellular GSK3β inhibitor of lithium for bone regeneration 
The intracellular molecules involved in the Wnt pathway also show promise in 
osteogenic therapeutic interventions. For instance, inhibiting GSK3β from 
phosphorylating β-catenin could stabilize the cytoplasmic β-catenin, allowing further 
progression through the Wnt downstream cascade. Lithium, a well characterized as a 
GSK3β inhibitor (Fig. 3-8 and Table 3-1), has been widely used as a long-term mood 
stabilizer in the treatment of bipolar and depressive disorders in the past 50 years. Its 
mode of action is enhancing the remyelination of peripheral nerves [169-171].  
Li
+
 has been reported to activate the canonical Wnt signalling pathway by inhibiting 
phosphorylating β-catenin in the cytoplasm, thereby targeting it for ubiquitination 
and degradation [172-174]. The effect of lithium on GSK3β was first investigated 
from the observation that lithium’s effects on Xenopus development were very 
similar to those caused by reductions of GSK3β activity. Furthermore, it revealed 
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that lithium directly binds and inhibits the phosphorylation of substrates of GSK3β, 
such as the microtubule associated protein tau [175]. Previous studies have shown 
that lithium chloride can stimulate the proliferation of retinoblastoma cells via 
elevated canonical Wnt signalling [176]; and the in vitro proliferation and neuronal 
differentiation of neural progenitor cells was enhanced by long-term treatment by 
lithium [177]. A study that is of particular interest for the application of Li
+
 ions in 
bone tissue engineering applications, is the finding that Li
+
 is capable of enhancing 
in vivo bone mass, and also activate the canonical Wnt signalling pathway in cultured 
calvarial osteoblasts from Lrp5
-/- 
 mice [12]. Additionally, mice treated with lithium 
after bone injury exhibited enhanced fracture healing [178].   
Table 3-1. The mode action of Scl-Ab and lithium in activation of canonical Wnt signalling 
Molecule 
of Wnt 
Physiological  role Target 
agent 
Mode of 
action 
Effects on osteogenesis 
Sclerostin Inhibits canonical 
Wnt signalling via 
binding LRP5/6 
Sclerostin 
antibody 
Neutralizes 
sclerostin 
 
Increased bone mass, density, and strength in 
OVX rats, aged male rats, and cynomolgus 
monkeys 
Phase I clinical trial: Dose-dependent 
increase in bone formation without adverse 
events 
GSK3β Inhibits canonical 
Wnt signalling via 
targeting β-catenin 
for proteosomal 
degradation 
Lithium inhibits 
GSK3β 
 
Restores bone mass in LRP5 KO mice and 
increases bone mass in WT mice 
Enhances fracture healing in mice 
Increased bone mass and density with 
increasing accumulated dose of clinical use 
of lithium 
GSK3β, glycogen synthase kinase 3β; KO, knockout; LRP, low-density lipoprotein receptor-related protein; 
OVX, ovariectomized; WT, wild type 
Increasing evidences demonstrated that Li may be associated with 
hyperparathyroidism, a risk factor for osteoporosis. The association between Li and 
enhanced bone formation in mouse models is consistent with epidemiological data in 
humans. Li can enhance fracture healing in mice, while clinically it reduces the 
incidence of fractures with increased bone mass and density with increasing 
accumulated dose of clinical use of lithium [178-180]. Its role in fracture healing is 
further demonstrated by increased β-catenin expression in fracture tissue in patients 
taking Li [181]. Yet, there are some reports that argue against the pharmacologic 
benefit of Li reducing fracture risks [182]. O. Cohan’s findings demonstrated 
although the clinical data does suggest an increase in bone turnover associated with 
lithium carbonate therapy treatment; however, no distinct effect was detected on 
bone density after short-or long-term lithium carbonate therapy, indicating that short- 
or long-term treatment with Li is not associated with increased risk for osteoporosis 
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[183]. These data demonstrated that GSK3β inhibitor of lithium possesses the 
promising osteogenic benefits. However, caution needs to be taken in over inhibiting 
GSK3β due to oncogenic risks. 
3.4 SUMMARY 
Periodontal regeneration especially cementum repair is a highly precise and 
programmed biological process that must be  robustly controlled using a proper time 
frame and sequence to enhance the wound healing process. Ultimately, it is now 
necessary to unveil the distinct spatial and temporal patterns of cellular and 
molecular events, especially canonical Wnt signalling involving cementogenesis and 
cementum regeneration with de novo generated Sharpey’s fibres tightly attached with 
the newly-formed cementoid. Tissue engineered cementum/periodontal tissues aim to 
mimic the natural structure of periodontium to guide periodontal regeneration in a 
physiological manner. This literature review summarizes natural anatomical structure 
and physiological functions of cementum in periodontal tissue development and 
regeneration. Also summarized is the potential applicable technology and scaffold 
materials for periodontal tissue engineering, and cells for cell-scaffold complex 
construction and strategies to engineer functional periodontium discussed based on 
current publications.  
This chapter highlighted on important role of canonical Wnt signalling in bone 
regeneration. It inspired me to investigate whether canonical Wnt signalling can 
induce cementum regeneration in vivo and whether suitable biomaterials could 
stimulate canonical Wnt signalling pathway and further induce cementum tissue 
regeneration. Therefore, the purpose of this study was to discuss in general terms 
canonical Wnt signalling pathway that potentially control cementum regeneration in 
vivo and in vitro. It can provide a new perspective to better understand the potential 
mechanism of canonical Wnt signalling activation that mediate periodontal repair 
and help us in designing new biomaterials that would coordinate the process of 
cementum/periodontal regeneration clinically. 
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Abstract 
The restoration of large periodontal defects due to periodontal diseases is a major 
challenge for regenerative therapy. It is well known that the canonical Wnt signalling 
plays a vital role in cell differentiation during cementogenesis. However, it is unclear 
whether canonical Wnt signalling pathway can effectively induce significant 
cementum repair in vivo for the regeneration of periodontal tissues and stimulate 
cementoinductive differentiation for human periodontal ligament cells (hPDLCs) in 
vitro. Therefore, the aim of this study was to investigate the interaction between 
canonical Wnt signalling activation and cementum repair using rat periodontal defect 
model and further explore hPDLCs cementogenic differentiation through activation 
of canonical Wnt signalling pathway. The results showed that the local activation of 
canonical Wnt signalling in rat periodontal defect area had significant new cellular 
cementum and well-organized periodontal ligament fibres formation, which was 
absent in the control group. In vitro experiments, using hPDLCs, showed that Wnt 
signalling pathway activator significantly increased mineralization, alkaline 
phospatase (ALP) activity, and gene and protein expression of bone and cementum 
markers of osteocalcin (OCN), osteopontin (OPN), cementum protein 1 (CEMP1), 
and cementum attachment protein (CAP). Our results suggest that activation of 
canonical Wnt signalling pathway can induce in vivo cementum regeneration and in 
vitro cementogenic differentiaiton of hPDLCs.  
Key words: The canonical Wnt signalling pathway; regenerative medicine; 
cementum regeneration; tissue engineering 
 
 
 
 
 
 
 
 
 
 
 44 Chapter 4: Activation of canonical Wnt signalling induces cementum regeneration 
4.1 INTRODUCTION 
The tissues forming the tooth-supporting apparatus of periodontium include alveolar 
bone, periodontal ligament (PDL), cementum, and gingival. Once the integrity of the 
peridontium has broken down, it is a major challenge for dental clinicians to restore 
its original structure and function by tissue regeneration [98]. By definition, 
regeneration of the lost periodontium involves the formation of all tooth-supporting 
structures including new cementum, PDL, alveolar bone and gingival tissue. In 
addition, the appropriate PDL tissue orientation, fibre directionality and integration 
to both cementum and alveolar bone are required for the function. Furthermore, 
appropriate mechanical loading is essential for the development of highly organized 
functional PDL fibres [184-185]. In periodontal tissue engineering and regeneration, 
cementum regeneration is a critical and challenging phase for the functional PDL 
formation, however, the molecular mechanisms underlying the regeneration process 
of cementum is poorly understood [185-186]. There are few, if any, reports 
describing the interaction between cell signalling pathways and periodontal tissue 
engineering, especially cementum regeneration. 
Cementum is a thin layer of mineralized tissue covering the tooth root surface and 
provides a mineralized interface for PDL to anchorage on tooth [90]. Increasing 
evidences demonstrated that cementogenesis is from dental mesenchymal cells in 
PDL differentiate to cementoblasts to form cementum [96-97]. Currently, PDLCs 
have been reported to be able to regulate the osteogenic differentiation during the 
process of periodontal regeneration; cell sheet of PDLCs have been confirmed to 
form new periodontal-cementum complex without/with growth factors indifferent 
animal models [19-20, 105]. However, the capacity of PDLCs to become 
cementoblast-like cells is not clear yet, let alone the molecular mechanisms behind 
such a process.  
Understanding the critical regulators associated with cementogenesis is of great 
importance for developing the molecular therapies for cementum regeneration. It is 
well known that canonical Wnt signalling is involved in multiple stages of tooth 
morphogenesis by mediating the transcription of the target genes [74, 89]. Recently, 
it has been demonstrated that the activation of the canonical Wnt signalling in 
osteoblasts and odontoblasts leads to aberrant dento-alveolar complex formation with 
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hypoplastic cementum and periodontal ligament in mice [77-78]. Furthermore, 
constitutive β-catenin stabilization in the dental mesenchyme leads to the excessive 
formation of dentin and cellular cementum in mice [76]. These data prompted us to 
ask whether activation of canonical Wnt signalling might assist in regeneration of 
cementum/periodontal tissues in vivo. Although its essential role in tooth 
morphologies is well documented, little is known about the involvement of canonical 
Wnt signalling pathway in the differentiation of PDL cells into cementum 
regeneration in vivo and in vitro.  
Experiments using neutralizing antibodies have shown that inhibition of sclerostin 
(Scl-Ab) could promote bone formation via activation of canonical Wnt signalling 
[10-11]. A similar effect is also seen with the administration of lithium chloride 
(LiCl), which by inhibiting GSK3β enhances bone healing by activating canonical 
Wnt signalling [175, 187]. In the present study, we tested the hypothesis that 
activation of the canonical Wnt signalling using either neutralizing Scl-Ab, lithium 
or overexpression of β-catenin can have favourable impact on rat periodontal wound 
healing. We sought to activate the canonical Wnt pathway during in vivo cementum 
regeneration in a rat periodontal defect model using the following approaches: (i) 
local injection of LiCl; (ii) local injection of a lentiviral construct overexpressing of 
β-catenin (LV-Ctnnb); and (iii) local injection of neutralizing Scl-Ab. Furthermore, 
the in vitro activation of the canonical Wnt pathway (by either LiCl or LV-Ctnnb) in 
human periodontal ligament cells (hPDLCs) was also performed to investigate the 
mechanism underlying cementoblast-like differentiation. Our data demonstrates that 
activation of the canonical Wnt signalling pathway can enhance cementum 
regeneration in vivo and in vitro.  
4.2 METHODS AND MATERIALS 
4.2.1 Rat periodontal defect model 
All animal procedures for this study were performed under guidelines approved by 
the Queensland University of Technology Animal Ethics Committee (approval no. 
1100000141). 12-week-old adult male Lewis rats (Rattus norvegicus, Strain-
LEW/CrlArc, Animal Resources Centre, WA, Australia) were anaesthetized by 
isoflurane (AttaneTM, Bomac Animal Health Pty Ltd, Australia) inhalation. A rat 
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periodontal defect model was created according to a previously published protocol 
[188].  
 
Figure 4-1. Rat periodontal defect model. (a) Schematic illustration of rat mandibular first 
molar. (b) Schematic illustration of periodontal fenestration defect. (c) Macroscopic 
observation of the periodontal defect during surgery. (d) The periodontal defect was 
successfully established. D: dentin; PDL: periodontal ligament; C: cementum; M1: 
mandibular first molar. 
Briefly, a vertical incision was made along the mesiopalatal side of the right buccal 
mandible. The mucoperiosteal flaps were subsequently elevated by dissection of the 
underlying masseter muscle and the periosteum covering the surface of first and 
second mandible molars to expose the mesial alveolar bone. The alveolar bone 
covering the root between first and second molar was removed with a dental bur with 
0.9% saline irrigation. The created periodontal window defect was approximately 1.5 
mm in width, 3 mm in length and 2mm in depth, in which all the periodontal 
ligament tissues and cementum on the tooth root surface were removed. The flap was 
re-positioned and pressed against the root surface and sutured (Fig. 4-1).The rats 
were sacrificed 7, 14, and 28 days after the surgery and all the mandibles (n=3 for 
each group at each time point) were harvested and fixed in 4% paraformaldehyde 
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(PFA) solution overnight at room temperature and then washed in phosphate 
buffered saline (PBS). 
4.2.2 Local administration of Scl-Ab and LiCl in rat periodontal defect 
To investigate the regenerative potential of the canonical Wnt signalling during 
periodontal regeneration, rats with periodontal defects were treated on a daily basis 
for 2 weeks with either vehicle (n=4) or Scl-Ab (humanized monoclonal Scl-Ab III, 
Amgen Inc., Thousand Oaks, CA, USA; n=4) or LiCl (Sigma-Aldrich, Australia; 
n=6). Scl-Ab and LiCl was administered locally into the periodontal defect site 
between the right mandible first and second molars and near the base of the in 
terproximal gingival papillae (at the dose of 25 mg/kg and 149 mg/kg respectively). 
Local injection of phosphate-buffered saline (1x PBS, Life Technologies, Australia) 
served as the vehicle control in the study. 
4.2.3 Local injection of LV-Ctnnb in rat periodontal defect 
To further confirm the effect of activation of the canonical Wnt signalling on 
periodontal regeneration, lentivirus particles containing rat gene of β-catenin (Ctnnb) 
were produced by 293T cell line which can be efficiently transduced by calcium 
phosphate DNA precipitation [189]. The HIV-1 lentivirus was produced by co-
transfection of 293T cells with 10 g plenti-CTNNB (Thermo Scientific, Australia) 
gene expression vector, 5 g of envelope vector pCMV-VSVG and 5 g of 
packaging plasmid pCMV-dR8.2. The medium was changed 12 hours after the 
transfection and then the lentivirus-containing medium was collected. LV-GFP 
without insert gene was used as control in this study. Virus concentration was 
determinate by transduction of 293T cells and quantification of transducted cells by 
flow cytometry for GFP expression. Lentivirus particles (1x10
9
) were locally 
administrated into the periodontal defect area with either LV-GFP (n=4) or LV-
Ctnnb (n=4) for 2 weeks. Local injection of 1xPBS (n=3) and LV-GFP (n=4) were 
served as the vehicle control. 
4.2.4 Micro‐computed tomography (μCT) scanning analysis 
Mandible bone specimens including first, second, and third molars were collected at 
the designated end points, placed in 4% paraformaldehyde for 24 hours and 
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transferred to 1xPBS for Micro-CT scanning. Tissues were scanned by micro-
computed tomography scanning (μCT40, SCANCO Medical AG, Brüttisellen, 
Switzerland) with high resolution of 12 m and a voltage of 45 kVp and a current of 
177 mA. The Three-dimensional (3D) images were reconstructed from the scans by 
the micro-CT system software. 
4.2.5 Histomorphometric analysis  
For histological analyses, jaws were dissected and fixed in 4% paraformaldehyde at 
4
o
C overnight. After rinsing with 1xPBS buffer, the specimens were decalcified in 
10% EDTA/PBS solution over a period of 4–8 weeks, and then embedded in 
paraffin. The samples were sectioned to a thickness of 5μm. Serial sections were 
performed by Hematoxylin & Eosin (H&E) staining. Heidenhain's AZAN trichrome 
(AZAN) staining was also carried out to determine newly formed cementum. AZAN 
staining provides optimal contrast with different colours, with cell nuclei (dark red) 
by azocarmine, collagen (blue) usinganiline blue. Histological and 
immunohistochemical images were captured with a Zeiss Axio Scope A1 
Microscope (Carl Zeiss Pty, Ltd, NSW, Australia).  
Newly-formed cementum was defined as mineralized tissue covering the root surface 
with cementocytes. The percentage of newly-formed cementum was calculated by 
dividing the length of the defect on the root surface. Percentage of new alveolar bone 
formation was calculated by dividing the area of new bone with the alveolar bone 
defect area. 
4.2.6 In situ hybridization and immunohistochemistry (IHC) analysis  
RNA-RNA in situ hybridization was assessed in this study to measure and localize 
mRNAs and transcripts within tissue sections. All samples were fixed overnight in 
4% formaldehyde solution at 4
o
C, decalcified in 1% EDTA and then embedded in 
paraffin. Antisense riboprobes labelled with digoxin were used for in situ 
hybridization. Probes of Axin2 were used for in situ hybridization for the canonical 
Wnt signalling. 
Immunohistochemical staining was carried out following de-waxing, hydration and 
endogenous peroxidase activity. Then the sections were incubated with Axin2 
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(1:500, rabbit anti-rat; Cell Signalling Technology, Inc., USA) primary antibody 
overnight at 4
o
C, followed by incubation, at room temperature with a biotinylated 
universal swine-anti-mouse, rabbit, goat secondary antibody (DAKO, CA, USA) for 
15 min, and then with horseradish perioxidase-conjugated avidin-biotin complex 
(DAKO, CA, USA) for another 15 minutes. The antibody complexes were visualized 
by the addition of a buffered diaminobenzidine (DAB) substrate for 4 minutes. 
Mayer’s haematoxylin (HD Scientific Pty Ltd.) was used for counter staining. 
4.2.7 Cell culture, proliferation and differentiation assay 
The isolation and culture of human periodontal ligament cells (hPDLCs) and human 
alveolar bone-derived osteoblasts (hOBs) were performed according to previously 
published protocols [190]. Informed consent was given by all patients involved and 
the research protocol had been approved by the Human Ethics Committees of 
Queensland University of Technology, Brisbane, Australia. hPDLCs and hOBs were 
cultured in Dulbecco’s Modified Eagle Medium (DMEM; Gibco-Invitrogen) 
supplemented with 10% v/v fetal bovine serum (FBS; Thermo Scientific) and 50 
U/mL penicillin and 50 mg/mL streptomycin (P/S; Gibco-Invitrogen) at 37
o
C in a 
humidified CO2 incubator. For osteogenic differentiation, cells were cultured in 
osteogenic DMEM medium containing 10% FBS, 50μg/ml ascorbic acid, 3mM β-
glycerophosphate and 10nM dexamethasone in the absence or presence of LiCl 
(Sigma-Aldrich, Australia) and LV-Ctnnb. 
Cell proliferation was assessed by MTT assay using the methods as described in our 
previous protocols [191]. Briefly, 0.5 mg/mL of MTT solution (Sigma-Aldrich, 
Australia) was added to each well and incubated at 37
o
C for 4 h to form formazan 
crystals. The formazan was solubilized with dimethyl sulfoxide and the absorbance 
read at 495 nm on a 96 well plate reader.  
Alizarin red staining was carried out as described before [192]. The medium was 
discarded and cells were fixed with ice-cold 100% methanol for 20 min, washed with 
PBS. Then the cells were stained with alizarin red for 5 min prior to observation. 
The relative ALP activity in the hPDLCs was assessed at day 7 and 14 after culture 
in osteogenic differentiation medium. Cells were lysed in a lysis buffer containing 
0.2% Triton X-100 and 50mM Tris-HCl. The whole cell lysis was measured using 
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QuantiChromTM Alkaline Phosphatase Kit (BioAssay System) by adding pNPP as a 
substrate assay buffer containing MgCl2, and then the kinetic of absorbance was read 
at 405nm. The enzyme activity was expressed as OD value per min per g of protein. 
The total protein in the cell lysis was measured using the BCATM Protein Assay Kit 
(PIERCE). 
The calcium concentration in hPDLCs was measured at day 7 and 14 in culture. Cells 
were washed twice by distilled water and incubated overnight in 0.6N HCl at 4
o
C. 
The dissolved calcium was assayed using a QuantiChrom Calcium Assay Kit 
(BioAssay System) following the manufacturer’s instructions.  
4.2.8 qRT-PCR and western blotting analysis 
Total cellular RNA was extracted using Trizol reagent (Life Technologies) according 
to the manufacturer’s instructions and reverse transcription was performed using a 
DyNAmo cDNA Synthesis Kit (FINNZYMES). The qRT-PCR primers for each 
gene are shown in Table 4-1. The quantitative real-time polymerase chain reaction 
(qRT-PCR) was performed using an ABI 7300 Real-Time PCR System and the 
relative gene expression was calculated using the following formula: 2-∆∆ Ct*104. 
Western Blotting analysis was performed for the detection of the protein expression. 
The protein concentration was determined by the BCA Protein Assay Kit (Thermo 
Fisher Scientific, Australia) and then 10 μg proteins from each sample were 
separated on 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and 
then transferred into a nitrocellulose membrane (Pall Corporation, East Hills, NY, 
USA). After blocking for 1 h with Odyssey® blocking buffer (Millennium Science, 
Australia), the membranes were incubated with the primary antibodies against ALP 
(1:1000, rabbit anti-human; Abcam), OCN (1:2000, rabbit anti-human; Abcam), 
CAP (1:1000, mouse anti-human; Santa Cruz Biotechnology), β-catenin (1:1000, 
rabbit anti-human; Cell Signalling Technology), Axin2 (1:2000 rabbit anti-human; 
Abcam) and GAPDH (1:1000, mouse anti-human; Abcam) overnight at 4
o
C and then 
with fluorescent secondary antibodies (1:4000, Cell Signalling Technology) and then 
targeted proteins were visualized using the Odyssey® infrared imaging system.  
4.2.9 Statistical analysis 
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Statistical analyses were performed using Statistical Package for Social Science 
(SPSS) version 21.0 software. Data were pooled by experimental groups and the 
mean and standard deviation (SD) were calculated. One way analysis of variance 
(ANOVA) followed by Student’s T-Test were performed for measuring statistically 
significant differences between groups for new alveolar bone formation and 
cementum formation; p values of less than 0.05 were considered to be statistically 
significant. 
4.3 RESULTS  
4.3.1 No cementum formation takes place during periodontal wound healing 
Four weeks after surgery, no visible adverse reactions, such as root exposure, 
infection, or suppuration, were observed. Initial inflammation immediately after 
surgery was comparable across all experimental groups. No acute inflammatory 
reaction was observed during the healing period. 3D micro-CT images were 
reconstructed to evaluate the primary healing of the defect at different time points. 
As shown in Fig. 4-2a, mineralized tissue covering the defect could be seen to 
increase with time. 
Periodontal tissue biopsies including gingival, alveolar bone and tooth were obtained 
at different time points. The representative images of H&E and AZAN staining 
showed that the new osteoblasts were formed along the surface of the old bone 
fragments at days 7 and 14 after surgery. At day 14, a high density of fibroblast-like 
cells had formed along the root surfaces of the surgical wounds. Newly deposited 
connective tissue fibres were formed along the root dentin surface, and the fibres 
were not well-oriented. At day 28, new bone formation could be seen mainly at the 
edge of old bone fragment. However, there was no new cementum found during this 
process (Fig. 4-2b, c). 
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Figure 4-2. Primary periodontal wound healing in control samples. (a) Representative µCT 
reconstruction images showing increased new bone formation (yellow arrow) with the time. 
(b) The representative H&E and AZAN staining images showed the periodontal remodelling 
process at 1, 2 and 4 weeks after the surgery. M1: mandibular first molar; D, dentin; AB, 
alveolar bone; PDL, periodontal ligament. 
4.3.2 Local activation of the canonical Wnt signalling with LiCl and Scl-Ab in 
established periodontal defect 
To elucidate the role of canonical Wnt signalling in alveolar bone repair, the Wnt 
signalling activators LiCl and anti-sclerostin primary antibody were injected locally 
to the periodontal defect area for two weeks. After 2 weeks, μCT analysis of samples 
from rats with LiCl and Scl-Ab injections showed a slight increase in alveolar bone 
compared with PBS injection control group (Fig. 4-3a and 4-4a).   
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Figure 4-3. Activation of canonical Wnt signalling inducing periodontal regeneration. (a) 
Representative µCT images of the periodontal healing process via activation of canonical 
Wnt signalling. (b, c) Representative images of H&E and AZAN staining for histological 
sections of periodontal defect 2 wks after the local injection at the surgical area. Scl-Ab and 
LiCl injection had new cemtum formation with well-orientated PDL fibres (black arrow) 
inserted, while vehicle group had no cementum formation. Black triangles indicate new 
cementocytes formed in newly-formed cementum. (d) Scl-Ab and LiCl significantly 
enhanced new cementum formation compared to control group. M1: mandibular first molar; 
D, dentin; AB, alveolar bone; PDL, periodontal ligament; NC, newly-formed cementum. 
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After analysis of H&E and AZAN histological staining of sections, the LiCl and Scl-
Ab injection groups had a significant increase of new cementum formation, whereas 
control groups showed no cementum formation along the root surface (Fig. 4-3 b, c). 
After 2 week of Scl-Ab injection, newly formed cementum was seen on the denuded 
root surface with well-orientated PDL collagen fibres inserted. The LiCl injection 
group, after 2 weeks of local injections, also showed obvious cementum formation 
with cementocytes entrapped and well-orientated Sharpey’s collagen fibres inserted. 
4.3.3 LiCl and Scl-Ab injections enhanced alveolar bone formation 
Histological analysis demonstrated that in all groups the original margin of the defect 
was still identifiable, and this made it possible to distinguish new bone from the old 
bone. Two weeks after injections, new bone formation could be observed in all 
groups; while the LiCl and Scl-Ab groups had enhanced new bone formation in the 
defect site along the old bone (Fig. 4-4). There was a significantly higher percentage 
of bone and cementum coverage for LiCl and Scl-Ab groups compared to PBS 
injection groups (Fig. 4-3d and 4-4d) (p < 0.05). 
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Figure 4-4. Enhanced alveolar bone formation via LiCl and Scl-Ab local injections. (a) After 
2 week’s injections, LiCl and Scl-Ab groups had induced bone formation between first molar 
cups (yellow arrow) compared to the PBS injection group. (b, c) Representative H&E and 
AZAN stained sections of the defects after 2 weeks injections. At 2 week, new bone was 
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observed in the LiCl and Scl-Ab injections groups, with PDL fibres inserted. D: Dentin; 
NAB: newly-formed Alveolar Bone; PDL: Periodontal Ligament; NC, newly-formed 
cementum. 
4.3.4 Regeneration mode: detection of Axin2 in periodontal regeneration tissues  
In situ hybridization and immunohistological analysis of AXIN2 expression were 
carried out to investigate whether the canonical Wnt signalling was activated in the 
defect area.  
Figure 4-5. In situ hybridization and IHC detection of AXIN2 expression in regeneration 
study. Representative sections showed that RNA (a) and protein (b) expression of AXIN2 
was increased in newly-formed PDL fibres (black triangle) and cementocytes (black arrow) 
via local activation of canonical Wnt signalling with LiCl and Scl-Ab for 2 weeks. Figure c 
demonstrated that LiCl and Scl-Ab not only enhanced newly-formed cementum, but also 
increased alveolar bone formation significantly, when compared to that of vehicle group. D: 
Dentin; PDL: Periodontal Ligament; NC, newly-formed cementum. 
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In situ hybridization showed weak Axin2 expression in the PBS injection control 
group. However, there was strong expression of Axin2 detected in newly-formed 
cementoblast-like cells and newly-formed periodontal fibres in LiCl and Scl-Ab 
groups (Fig. 4-5a), indicating the activation of canonical Wnt signalling in local 
periodontal defect area. IHC data confirmed that protein expression pattern of Axin2 
was observed locally in periodontal defect area. Activation of canonical Wnt 
signalling with LiCl and Scl-Ab not only increased new cementum formation but 
also led to the increased new alveolar bone formation (Fig. 4-4c). 
4.3.5 Overexpression of β-catenin facilitates periodontal regeneration  
To further confirm whether activation of canonical Wnt signalling has enhanced 
effect of cementum regeneration, lentivirus particles for overexpression of Ctnnb 
were injected locally in periodontal defect area for two weeks. Confocal laser 
scanning microscopy (CLSM) images provided evidence of newly-formed 
cementocytes and well-oriented PDL fibres with strong GFP expression in LV-Ctnnb 
injected animals compared to controls (Fig. 4-6a). The representative H&E and 
AZAN staining images showed that LV-Ctnnb had enhanced cementum formation 
with well-ordered PDL fibres (Fig. 4-6 b, c). 
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Figure 4-6. Overexpression of Ctnnb facilitates periodontal regeneration after 2 weeks. (a) 
After injection of LV-Ctnnb for two weeks, newly-formed cementocytes (yellow triangles) 
formed with well-oriented PDL fibres (yellow arrows) inserted compared to LV-GFP group. 
(b) Higher magnification of GFP-positive cementocytes (yellow triangle) in different groups. 
(c) The representative H&E and AZAN staining images show LV-Ctnnb increased 
cementum and PDL fibres formation. D: Dentin; PDL: Periodontal Ligament; NC, newly-
formed cementum, AB, alveolar bone. 
4.3.6 Activation of canonical Wnt signalling pathway during hPDLCs osteogenic 
differentiation 
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LiCl induced activation of canonical Wnt signalling was carried out to investigate 
whether it can regulate osteogenic differentiation of hPDLCs. The effect of different 
concentrations of LiCl on proliferation of hPDLCs was assessed by MTT test. The 
MTT assay results showed that LiCl significantly stimulated proliferation of hPDLCs 
compared to control group in 1, 3 and 7 days culture; 5mM of LiCl was the optimum 
concentration for proliferation (Fig.4-7c). The mineralization was examined using 
Alizarin Red staining, relative ALP activity and intracellular calcium assay. As 
shown in Supplemental Fig. 1a, the cultures treated with LiCl for 14 days showed a 
dose-dependent increase of calcium precipitation and matrix mineralization. In 
parallel with this result, LiCl also increased relative ALP activity and intracellular 
calcium amount as revealed by calcium assay (Fig.4-7c).  
 
Figure 4-7. Activation of canonical Wnt signalling enhanced proliferation and 
differentiation for hPDLCs. (a, b) The Alizarin red staining and cell proliferation assay for 
hPDLCs in the presence of different concentrations of LiCl. (c) LiCl increased relative ALP 
activity and calcium concentration for hPDLCs with different time points.  
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4.3.7 Cementogenic/osteogenic gene/protein expression and signalling pathway for 
hPDLCs 
Quantitative RT-PCR and western blot analysis were carried out to investigate the 
effect of LiCl treatment on cementoblastic/osteogenic differentiation markers in 
hPDLCs, (Fig. 4-8). The results showed that the gene expressions of the osteogenic 
markers OCN and OPN increased in the presence of LiCl over time compared to 
control group (Fig. 4-8) as did the expression of the cementogenic markers CEMP1 
and CAP (Fig. 4-8b).  
 
Figure 4-8. Activation of canonical Wnt with LiCl increased bone and cementum-related 
gene/protein expression for hPDLCs. The relative gene expression of osteogenic markers of 
OPN, OCN (a), cementum-related markers of CEMP1, CAP (b) and Wnt-related genes of 
AXIN2, CTNNB (c) for hPDLCs in the presence of LiCl. O/OM: osteogenic differentiation 
medium. 
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The analysis of the expression of canonical Wnt-related genes such as AXIN2 and 
CTNNB was performed by qRT-PCR after culturing hPDLCs with LiCl (5mM) for 3, 
7 and 14 days. The results showed that the expression of AXIN2 and CTNNB of 
hPDLCs in the presence of LiCl was significantly higher than control group at day 3, 
7 and 14 (Fig. 4-8c). 
 
Figure 4-9. LiCl had enhanced protein expression for cementogenic/osteogenic and Wnt-
related genes after 7 days culture. O/OM: osteogenic differentiation medium. 
Western blot analysis was performed on the protein expression of hPDLCs cultured 
with LiCl for 7 days. The protein expression of bone/cementum markers (OPN, 
CAP) and Wnt-related proteins (AXIN2, β-CATENIN) increased as the result of 
LiCl compared to two other groups (Fig. 4-9).  
4.3.8 The effect of CTNNB overexpression on hPDLCs differentiation 
hPDLCs were infected with LV-Ctnnb lentivirus to explore the effect of Ctnnb 
overexpression in these cells. Strong GFP expression demonstrated that the hPDLCs 
had been successfully infected by lentivirus (Fig. 4-10a). CTNNB gene/protein 
expression assays further confirmed that LV-Ctnnb infected hPDLCs activated 
canonical Wnt signalling, resulting in enhanced CAP and β-catenin protein 
expression (Fig. 4-10 b, c). 
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Figure 4-10. Overexpression of Ctnnb for hPDLCs. (a) GFP expression was indicated after 
transduction with lentivirus containing Ctnnb gene. (b) To confirm LV-Ctnnb transduction 
with enhanced expression of Ctnnb. (c) LV-Ctnnb increased CAP and Ctnnb protein 
expression. Cells without lentivirus transduction and LV-GFP were used as control. 
4.3.9 Canonical Wnt signalling in differentiation of osteoblasts  
To investigate the role of canonical Wnt signalling in alveolar bone derived 
osteoblasts cementogenic differentiation, LiCl were applied in the culture medium. 
qRT-PCR results showed a failure of osteoblasts to express CAP gene and protein in 
response to LiCl treatment (Fig. 4-11). However, LiCl treatment did result in 
enhanced AXIN2 and β-catenin protein expression osteoblasts (Fig. 4-11). 
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Figure 4-11. Activation of canonical Wnt signalling for hOBs. (a) The gene expression of 
canonical Wnt signalling of AXIN2 and CTNNB for hOBs in the presence of LiCl. (b) CAP 
expression for hOBs under culture with LiCl. (c) hOBs had no CAP protein expression under 
activation of Wnt signalling with enhanced AXIN2 and CTNNB protein expression. 
4.4 DISCUSSIONS 
This study was conducted to investigate the interaction between activation of 
canonical Wnt signalling pathway and cementum repair/regeneration in vivo and in 
vitro. To the best of our knowledge, this is the first study of its kind, which activates 
canonical Wnt signalling in vivo by local injection of LiCl, Scl-Ab and LV-Ctnnb 
into a periodontal defect. The results showed that the activation of canonical Wnt 
signalling stimulates de novo alveolar bone formation, with well-orientated PDL 
fibres and cementum formation. In addition, the regulation of canonical Wnt 
signalling was also investigated in vitro for hPDLCs proliferation and 
osteogenic/cementogenic differentiation. These data indicate that canonical Wnt 
signalling pathway is an important regulator for cementum regeneration and suggests 
this signalling pathway can be a promising target for the treatment of periodontal 
disease. 
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The rat is frequently used as a model for studies of periodontal disease and tissue 
regeneration due to cost effectiveness and ease of handling; however, the typical 
defect size is relatively small, which makes the defect creation a challenging task. It 
is particularly difficult, during the bone and cementum removal process, to irrigate 
with saline due to the small defect size, and thin bone and cementum [193-194]. We 
can report that in this study, therat model of periodontal defect was successfully 
established, with the exposed tooth root surface documented by macroscopic and 
micro-CT observations. Although some periodontal tissues were formed 4 weeks 
after the surgery, including periodontal ligament fibres and alveolar bone, the 
cementum still lags behind in terms of repair during the natural healing progress 
following the periodontal defect surgery.  
There is much evidence to support the essential role of canonical Wnt signalling in 
tooth development and the transition of tooth morphogenesis from bud to cap stage, 
suggesting the potential use of Wnt activation in strategies for tooth regeneration 
[74]. However, the molecular mechanism of canonical Wnt signalling in cementum 
regeneration is largely unknown. Many studies suggested that LiCl and anti-
sclerostin neutralizing antibody could enhance the in vitro cell proliferation and 
improve bone mass in mice in vivo by activating canonical Wnt signalling pathway 
[12, 174, 195]. For this reason, it is important to elucidate the involvement of 
canonical Wnt signalling pathway with cementum repair to establish its role during 
periodontal tissue engineering.  
The pharmacological inhibition of sclerostin using neutralizing monoclonal 
antibodies have been studied in clinical trials for postmenopausal osteoporosis, and 
in preclinical models of osteoporosis, bone repair, and fracture healing [164-165, 
167]. Moreover, oral use of lithium has been used to treat humans with bipolar 
disease for over a half-century, with substantial benefit [169-171]. Few studies have 
specifically addressed the effect of lithium therapy on bone metabolism. Lithium 
therapy has been shown to not only increase bone mass and density clinically with 
increasing accumulated dose use but also restore bone mass in LRP5 knockout mice 
and increase fracture healing in mice [175, 187]. In both the preclinical and clinical 
settings, administration of Scl-Ab and LiCl is consistently associated with increased 
bone formation and bone density at several sites throughout the body and has been 
linked to activation of canonical Wnt signalling; however, effects within the 
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periodontal complex have never been studied. Experiments were, therefore, designed 
to compare the transcriptional events induced by LiCl and Scl-Ab. Importantly, 
similar results were obtained in terms of newly-formed cementum, alveolar bone and 
periodontal fibres, suggesting that both LiCl and Scl-Ab act in a similar fashion to 
induce new cementum/periodontal regeneration. 
Our study provides early preclinical evidence that Scl-Ab and LiCl have an ongoing 
role in periodontal regeneration. We can report that within 2 weeks of local 
administration of Scl-Ab and LiCl in periodontal defect sites, alveolar bone showed 
significantly greater bone volume and mineral density relative to vehicle control. 
More importantly, it was observed that the Scl-Ab and LiCl treatment groups had 
significantly enhanced de novo cementum regeneration with well-organized 
periodontal ligament fibres inserted compared to the control group.  
Axin2 is recognised as the most accurate reporter gene in canonical Wnt pathway 
since it is a direct target gene of Wnt ligand binding and activation of the Wnt 
signalling pathway [83] and has been found to be expressed during the tooth 
formation including the crown and root developments [83, 89]. In this study, in situ 
hybridization and IHC results demonstrated that Axin2 transcript/protein expression 
was increased in response to Scl-Ab and LiCl treatments compared to the controls, 
whereas there was only weak Axin2 expression of in PBS injection group. The 
Axin2 expression coincided with newly-formed Sharpey’s fibres and cementocytes 
in the LiCl and Scl-Ab treatment groups, indicating that activation of canonical Wnt 
signalling is correlated with periodontal regeneration. It is anticipated that the role of 
the canonical Wnt signalling will share a similar pattern between early 
cementogenesis and cementum regeneration, which may provide evidence to 
promote an entirely new approach for cementum regeneration.  
β-catenin is a critical member of Wnt/β-catenin signalling pathway, and although its 
expression is not directly linked to the activation of the Wnt pathway, it is the 
inhibition of its cytoplasmic degradation that is the direct consequence of the 
upstream activation of the pathway [71-72]. Overexpression of β-catenin in this 
study enhanced cementum formation with well-oriented PDL fibres inserted 
compared to control groups. 
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A number of experimental studies have previously demonstrated that hPLDCs can be 
differentiated into osteoblasts, fibroblasts and cementoblast-like cells in vivo and in 
vitro, a process which is mediated by BMP-like molecules [19-20, 105]. Recent 
findings demonstrated that the Wnt/β-catenin signalling pathway stimulates cell 
proliferation and osteoblastic differentiation in hPDLCs [196-197]. However, it is 
unknown whether canonical Wnt signalling is involved with hPDLCs 
osteogenic/cementogenic differentiation. In this study, LiCl, a GSK-3β inhibitor, was 
used to examine the possible involvement of the canonical Wnt signalling in 
regulating hPDLCs behaviour. In agreement with many recent reports, our results 
showed that activation of canonical Wnt signalling could enhance the expression of 
late osteoblasts makers OPN and OCN, and the cementobolast-related markers CAP. 
As a control group, human alveolar bone-derived osteoblasts showed no expression 
of CAP in the presence of activated canonical Wnt signalling (S. Fig. 2). These 
findings indicate that hPDLCs are the responsible cell type to differentiate into 
osteoblast/cementoblast-like cells compared to hOBs. 
Several issues must be considered before the use of lithium and Scl-Ab as potential 
therapeutic targets to regenerate cementum and periodontal tissues becomes a viable 
option. For instance, over-activation of canonical Wnt signalling may be 
tumorigenic. Short-term lithium treatment (60 days) in mice with the cancer 
predisposing Apc mutations caused a modest increase in tumor size and, more 
importantly, it has been reported that rates of cancer increased in patients receiving 
chronic lithium therapy [198-199]. Another consideration is whether local 
administration of lithium or Scl-Ab in the oral environment may in fact have 
detrimental effects on the periodontal regeneration. More in depth studies would 
need to be conducted with gradient concentrations of LiCl and Scl-Ab on periodontal 
regeneration, especially in cementum regeneration. Although Scl-Ab showed 
increased cementum formation during periodontal healing, this is a costly reagent 
with a short half-life, whereas lithium is inexpensive and its ion release can be 
carefully controlled to activate canonical Wnt signalling. For this reason, lithium was 
the focus of the in vitro experiments in this study. There is also the issue of what 
constitute cementum-specific markers. Although cementum attachment protein 
(CAP) has been reported as a cementum-specific marker, PDL tissues also express 
CAP strongly [200]. This makes it challenging to distinguish between what is 
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osteogenic differentiation and cementogenic differentiation. This problem can only 
be solved by identifying yet unknown cementum-specific markers. 
We put forward the hypothesis that activation of canonical Wnt signalling pathway 
could be a beneficial therapy for in vivo cementum repair and regeneration; however, 
this concept needs to be further investigated with other regulators of the Wnt 
signalling pathway. Additionally, future evaluation of cementum forming capacity is 
required in large animal models to demonstrate that canonical Wnt signalling can 
initiate bone/cementum regeneration as well as its crosstalk with other signalling 
pathways in the relation to differentiation of PDLCs to cementoblasts.  
4.5 CONCLUSIONS 
In summary, local injections of LiCl, Scl-Ab and LV-Ctnnb in a rat periodontal 
defect model resulted in de novo cementum formation with well-orientated PDL 
fibres, via the regulation of canonical Wnt signalling pathway. The canonical Wnt 
signalling activation by LiCl and LV-Ctnnb significantly enhanced cell proliferation, 
and bone/cementum-related gene/protein expression in hPDLCs. Targeting canonical 
Wnt signalling pathway may provide a new potential application in periodontal tissue 
regeneration. 
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Abstract  
Lithium (Li) has been widely used as a long-term mood stabilizer in the treatment of 
bipolar and depressive disorders. Li
+
 ions are thought to enhance the remyelination 
of peripheral nerves and also stimulate the proliferation of neural progenitor cells and 
retinoblastoma cells via activation of the canonical Wnt signalling pathway. Until 
now there have been no studies reporting the biological effects of released Li
+
 in 
bioactive scaffolds on cemetogenesis in periodontal tissue engineering applications. 
In this study, parts of Li
+
 ions were incorporated into the mesoporous bioactive glass 
(MBG) scaffolds and showed that this approach yielded scaffolds with a favourable 
composition, microstructure and mesopore properties for cell attachment, 
proliferation, and cementogenic differentiation of human periodontal ligament-
derived cells (hPDLCs). This study went on to investigate the biological effects of 
Li
+ 
ions themselves on cell proliferation and cementogenic differentiation. The 
results showed that 5% Li
+
 ions incorporated into MBG scaffolds enhanced the 
proliferation and cementogenic differentiation of hPDLCs on scaffolds, most likely 
via activation of the canonical Wnt signalling pathway. Further study demonstrated 
that Li
+
 ions by themselves significantly enhanced the proliferation, differentiation 
and cementogenic gene expression of hPDLCs. These results indicate that 
incorporation of Li
+
 ions into bioactive scaffolds is a viable means of enhancing the 
canonical Wnt signalling pathway to stimulate cementogenic differentiation of 
hPDLCs. 
Keywords: Lithium; Bioactive scaffolds; Cementum/periodontal tissue engineering; 
Gene expression; Signalling pathway 
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5.1 INTRODUCTION 
For the past 50 years, Lithium (Li
+
) has been widely used as a long-term mood 
stabilizer in the treatment of bipolar and depressive disorders and its mode of action 
is thought to be by enhancing the remyelination of peripheral nerves [169-171]. Li
+
 
has been also been reported to activate the canonical Wnt signalling pathway by 
inhibiting glycogen synthase kinase-3β (GSK-3β), an enzyme that phosphorylates β-
catenin in the cytoplasm, thereby targeting it for ubiquitination and degradation [172-
174]. Previous studies have shown that lithium chloride can stimulate the 
proliferation of retinoblastoma cells via elevated the canonical Wnt signalling [176]; 
and the in vitro proliferation and neuronal differentiation of neural progenitor cells 
was enhanced by long-term treatment by lithium [177]. A study that is of particular 
interest for the application of Li
+
 ions in bone tissue engineering applications is the 
finding that Li
+
 is capable of enhancing in vivo bone mass, and also activating the 
canonical Wnt signalling pathway in cultured calvarial osteoblasts from Lrp5
-/- 
 mice 
[12].  
The treatment of periodontital diseases is a major challenge due to difficulties in 
periodontal tissue regeneration, especially the cementum. Periodontal tissue 
engineering has come into focus as an alternative approach for the regeneration of 
alveolar bone, root cementum, and periodontal ligament [98, 201-203]. Human 
periodontal ligament cells (hPDLCs) have the capacity in vitro to differentiate into 
osteoblasts and cementoblasts [204] due to the multilineage differentiation potential 
[110]. The cementogenic differentiation of hPDLCs is spatially and temporally 
regulated by the cell signalling proteins and genes and influenced by the ions 
presented in the culture media[205]. In the previous study, it has demonstrated that 
the stem cell transplantation can lead to the formation of new cementum, however 
stem cell transplantation to periodontal site is still a clinically challenged technique 
to deliver.  It is known that bioactive scaffolds play an important role to influence the 
biological response of tissue cells and the subsequent tissue formation [206-207]. It 
is, therefore, of great clinical relevance to design bioactive scaffolds with properties 
that stimulate the cementogenic differentiation of PDLCs for better periodontal 
regeneration application. As such, mesoporous bioactive glass (MBG) has attracted 
significant attention in recent years [128, 191, 208-211]. The significant feature of 
MBG, compared with non-mesopore bioactive glass (NBG), is that it possesses 
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significantly improved specific surface area and nanopore volume which is 
evidenced by greatly enhanced apatite-mineralization ability and degradation [208, 
212-213]. It has been demonstrated that MBG has improved in vitro and in vivo 
bioactivity, degradation and drug delivery properties, compared to NBG [214-215] 
and, as a bioactive material; MBG has great potential for cementum/periodontal 
regeneration applications. In an earlier study Li
+
 was incorporated into 45S5 bioglass 
disks (not scaffolds) and was found that Li
+
 could influence the apatite-
mineralization of 45S5 bioglass with a dose-dependent way [216]. However, there is 
no study about how Li-containing biomaterials and Li
+
 ions influence the 
cementogenic differentiation of cells.  
With these earlier studies in mind, it is reasonable to hypothesise that the 
incorporation of Li
+
 ions into MBG scaffold system may improve the cementogenic 
differentiation of PDLCs for periodontal tissue engineering application. Therefore, 
the aim of this study, therefore, was to prepare Li
+
-containing bioactive scaffolds and 
then investigate the effect of Li
+
 ions released from the scaffolds on the proliferation 
and cementogenic differentiation of hPDLCs.  
5.2 MATERIALS AND METHODS 
5.2.1 Preparation and characterization of porous Li-MBG scaffolds 
Porous lithium-containing mesopore-bioglass (Li-MBG) scaffolds were prepared by 
incorporating Li (molar: 0, 2 and 5%) into MBG using co-templates of non-ionic 
block polymer P123 (EO20-PO70-EO20) and polyurethane sponges. P123 is used to 
produce mesoporous structures (mesopore size: around 5 nanometers) and 
polyurethane sponges are used to create large pores (large pore size: 300-500 
hundred micrometers) as described in previous publications [191, 211]. To prepare 
MBG scaffolds containing of 5% Li, 6 g of P123 (Mw=5800, Sigma-Aldrich), 10.1 g 
of tetraethyl orthosilicate (TEOS, 98%), 1.4 g of Ca(NO3)2·4H2O, 0.125 g of LiCl 
(Sigma-Aldrich), 1.10 g of triethyl phosphate (TEP, 99.8%) and 1.5 g of 0.5 M HCl 
were dissolved in 90 g of ethanol (Li/Ca/P/Si/ = 5/10/5/80, molar ratio, named 5Li-
MBG) and stirred at room temperature for 1 day. The polyurethane sponges (25ppi) 
were cleaned and completely immersed into this solution for 10 min, then transferred 
to a Petri dish to allow evaporating at room temperature for 12 h. This procedure was 
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repeated three times. Once the samples were completely dry, they were calcined at 
700
o
C for 5 h yielding the 5Li-MBG scaffolds. MBG scaffolds without Li 
(Li/Ca/P/Si/ = 0/15/5/80, molar ratio, named: MBG) and with 2% Li (Li/Ca/P/Si/ = 
2/13/5/80, molar ratio named: 2Li-MBG) were prepared by the same method except 
for their Li and Ca contents.  
The large-pore structure and inner microstructure of the calcined Li-MBG scaffolds 
were characterized by scanning electron microscopy (SEM) and transmission 
electron microscopy (TEM). 
5.2.2 Isolation and culture of human periodontal ligament cells (hPDLCs) 
Isolation and culture of human PDLCs were performed according to previously 
published protocols [20]. Teeth were obtained from healthy patients (n=3, 18–25 
years old) undergoing third molar extraction surgery. Informed consent was given by 
all patients involved and the research protocol had been approved by the Human 
Ethics Committees of Queensland University of Technology, Brisbane, Australia. 
Periodontal ligament tissues were separated from the middle third of the root surface 
using a scalpel and were cultured in a T25 flask in Dulbecco’s Modified Eagle 
Medium (DMEM; Gibco-Invitrogen) supplemented with 10% v/v fetal bovine serum 
(FBS; Thermo Scientific) and 50 U/mL penicillin and 50 mg/mL streptomycin (P/S; 
Gibco-Invitrogen) at 37
o
C in a humidified CO2 incubator. The medium was changed 
after five days and the outgrown cells growing around the PDL tissues were passaged 
at approximately 80% confluence and expanded through two passages to obtain a 
sufficient number of cells for the in vitro assays. Cells at passages P2–P5 were used 
for the study. 
5.2.3 Morphology and proliferation of hPDLCs on Li-MBG scaffolds 
At an initial density of 1 x 10
5
cells/scaffold, PDLCs were cultured on 5×5×5 mm Li-
MBG scaffolds placed in 48-well culture plates. After culture for 7 days in DMEM 
culture medium with 10% FBS, the scaffolds were removed from the culture wells, 
rinsed in PBS, and then fixed with 2.5% glutaraldehyde in PBS for 1 h. After 
washing with buffer containing 4% (w/v) sucrose in PBS and post fixed in 1% 
osmium tetroxide in PBS, the scaffolds were dehydrated in ethanol series (50, 70, 90, 
95 and 100%) and hexamethyldisilizane (HMDS) and then all the specimens were 
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coated with gold. Using SEM, the morphological characteristics of the attached cells 
was performed. 
Cell proliferation was assessed by MTT assay using the methods as described in 
previous protocols [191]. Briefly, an 0.5 mg/mL of MTT solution (Sigma-Aldrich) 
was added to each scaffold and incubated 37
o
C to form formazan crystals. The 
culture media was removed and the formazan was solubilized with dimethyl 
sulfoxide (DMSO) after 4 h. The absorbance of the formazan-DMSO solution was 
read at 495 nm using a plate reader. All the results were demonstrated as the optical 
density values minus the absorbance of blank wells. 
5.2.4 Relative alkaline phosphatase (ALP) activity and calcium concentration test 
of hPDLCs on Li-MBG scaffolds 
The relative ALP activity was assessed at day 7 and 14 after hPDLCs cultured in Li-
MBG scaffolds with a seeding density of 1x10
5
 per scaffold. Briefly, the cells were 
washed with PBS three times to remove the media, and then lysed in 200 μL of 0.2% 
Triton
®
 X-100. Lysates were centrifuged at 14,000 rpm for 5 min at 4
oC and 50 μL 
of supernatants mixed with 150 μL ALP assay working solution according to the 
manufacturer’s protocol (QuantiChromTM Alkaline Phosphatase Assay Kit, BioAssay 
Systems, USA). The total protein content was measured by the bicinchoninic acid 
protein assay kit (Thermo Scientific, Australia). The optical density (OD) was 
measured at 405 nm on a plate reader. The relative ALP activity was obtained as the 
changed OD values divided by the reaction time and total protein content. 
The calcium concentration of hPDLCs was measured at day 7 and 14 in culture on 
the Li-MBG scaffolds. The cells were washed with ddH2O three times to remove the 
medium, then lysed in 100 μL of 0.6N HCl. The lysates were centrifuged at 14,000 
rpm for 15 min at 4
oC and 5 μL of  supernatant mixed with 200 μL of the assay 
working solution according to the manufacturer’s protocol (QuantiChromTM Calcium 
Assay Kit, BioAssay Systems, USA). 
5.2.5 Cementogenic-related gene expression of hPDLCs on Li-MBG scaffolds 
The effect of Li-MBG scaffolds on hPDLCs cementogenic differentiation was 
assessed by real-time quantitative PCR (RT-qPCR) to measure the mRNA 
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expression of alkaline phosphatase (ALP),osteopontin (OPN), osteocalcin (OCN), 
cementum protein 1 (CEMP1) and cemtum attached protein (CAP) in all treatment 
groups (Table 5-1). The media was changed after 24 h to osteogenic differentiation 
medium after 1 x 10
6
 hPDLCs cultured in each scaffold. Cells were harvested on day 
3 and 7 and then total RNA was isolated using Trizol Reagent
®
 (Invitrogen) 
according to the manufacturer’s instructions. From 1 µg total RNA, complementary 
DNA was synthesized using DyNAmo
TM
 cDNA Sythesis Kit (Finnzymes, 
Genesearch, Australia) following the manufacturer’s instructions. RT-qPCR primers 
were designed based on cDNA sequences from the NCBI Sequence database and the 
primer specificity was confirmed by BLASTN searches. RT-qPCR was performed on 
an ABI Prism 7300 Thermal Cycler (Applied Biosystems, Australia) with SYBR 
Green detection reagent. Briefly, 2.5 µL of cDNA template, 2.5 µL of gene-specific 
reverse and forward primers (GeneWorks Pty Ltd, Australia) and 12.5 µL of 
2×SYBR Green qPCR Master Mix (Invitrogen) was mixed with 5 µL RNAse free 
water for a 25 µL final reaction volume in a 96-well PCR plate. The relative mRNA 
expressions of ALP, OPN, OCN, CEMP1 and CAP were assayed and normalized 
against the house keeping gene GAPDH. Each sample was performed in triplicate. 
The mean cycle threshold (Ct) value of each target gene was normalized against Ct 
value of GAPDH and the relative expression calculated using the following formula: 
2
-(normalized average Cts) 
×10
4
. 
Table 5-1. Primer pairs used in qRT-PCR analysis 
Gene Forward primer Reverse primer 
ALP 5' TCAGAAGCTAACACCAACG 3' 5' TTGTACGTCTTGGAGAGGGC 3' 
OPN 5' TCACCTGTGCCATACCAGTTAA 3' 5' TGAGATGGGTCAGGGTTTAGC 3' 
OCN 5' GCAAAGGTGCAGCCTTTGTG 3' 5' GGCTCCCAGCCATTGATACAG 3' 
CEMP1 5' GGGCACATCAAGCACTGACAG 3' 5' CCCTTAGGAAGTGGCTGTCCAG3' 
CAP 5' CTGCGCGCTGCACATGG 3' 5' GCGATGTCGTAGAAGGTGAGCC 3' 
AXIN2 5' CCCCAAAGCAGCGGTGC 3' 5' GCGTGGACACCTGCCAG 3' 
CTNNB 5'GCTACTGTTGGATTGATTCGAAATC 3' 5'CCCTGCTCACGCAAAGGT 3' 
GAPDH 5' TCAGCAATGCCTCCTGCAC 3' 5' TCTGGGTGGCAGTGATGGC 3' 
18s 5’ TTCGGAACTGAGGCCATGAT 3' 5’ CGAACCTCCGACTTCGTTC 3' 
5.2.6 The canonical Wnt signalling related gene expression of hPDLCs on Li-
MBG scaffolds 
To investigate the effect of Li-MBG scaffolds on canonical Wnt signalling related 
the gene expression for hPDLCs and Wnt/β-catenin related genes (AXIN2, β-
CATENIN) were analysed by RT-qPCR as described above. 
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5.2.7 Ion release from Li-MBG scaffolds 
To investigate the ion release of Li-MBG scaffolds, the cell culture medium was 
collected after cell culturing for set periods. The ionic concentrations of Li, Ca, P, 
and Si ions in the medium were determined by inductive coupled plasma atomic 
emission spectrometry (ICP-AES) (Perkin-Elmer Optima 7000DV).  
5.2.8 The effect of Li ions on cementogenic-relative gene expression of hPDLCs 
To further investigate the effect of Li ions on the cementum-related genes expression 
of hPDLCs, ALP, OPN, OCN, CEMP1 and CAP were carried out by RT-qPCR. 
5.2.9 Statistical analysis 
All the analysis was performed using SPSS software (SPSS Inc., Chicago, Il, USA). 
All the data were showed as means ± standard deviation (SD) and analyzed using 
one-way ANOVA with a Student’s T-test; p-values < 0.05 were considered 
statistically significant.  
5.3 RESULTS 
5.3.1 Characterization of porous Li-MBG scaffolds 
TEM analysis reveals that both MBG and 5Li-MBG scaffolds had a well-ordered and 
uniform mesoporous channel structure with the pore size of 50 nm in the inner of 
matrix (Fig. 5-1). 
 
Figure 5-2.  TEM analysis for 0Li-MBG (a) and 5Li-MBG (b) scaffolds. 
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Figure 5-2. SEM analysis for 0Li-MBG (a, b), 2Li-MBG (c, d) and 5Li-MBG (e, f) 
scaffolds. (b), (d) and (f) are high magnification images. 
SEM analysis revealed that the Li-MBG scaffolds (0, 2 and 5% Li
+
) all had a highly 
porous structure with similar large-pore sizes ranging from 300 to 500 µm (Fig. 5-2a, 
c, and e). Higher magnification images showed smooth surfaced pore walls and no 
significant difference between the three scaffolds types (Fig. 5-2 b, d and f). 
5.3.2 Attachment, morphology, proliferation of hPDLCs on Li-MBG scaffolds 
Human PDLCs attachment and morphology on the Li-MBG scaffolds was examined 
by SEM (Fig. 5-3). After 7 days in culture, hPDLCs were attached to the surface of 
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the pore walls in all three scaffolds types. Cells were in close contact with the 
scaffold surfaces and had numerous filopodia. 
 
Figure 5-3. The attachment of hPDLCs on 0Li-MBG (a), 2Li-MBG (b) and 5Li-MBG 
scaffolds after culturing for 7 day. 
MTT analysis showed that the number of cell increased with length of time in culture 
(Fig. 5-4a). The cell number on 5Li-MBG scaffolds was greater than that of the 2Li-
MBG and MBG scaffolds at 7 days. Overall, the rate of cell proliferation on 5Li-
MBG scaffolds was significantly higher than that on pure MBG or 2Li-MBG 
scaffolds with increased time in culture. 
5.3.3 ALP activity and calcium content of hPDLCs on Li-MBG scaffolds 
The relative ALP activity of hPDLCs on the 5Li-MBG scaffolds showed a 
significant increase compared to other two groups (p<0.05) at both 7 and 14 days 
(Fig. 5-4b). There was no significant difference for the calcium deposition across the 
three scaffold types (Fig. 5-4c). 
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Figure 5-4. The cell proliferation (a), relative ALP activity (b) and calcium mineralization 
concentration (c) of hPDLCs on three scaffolds. *: significant difference (p<0.05) for 5Li- 
MBG group compared to other two groups (5Li: 0.1219±0.020076; 2Li:0.0897±0.010978; 
0Li:0.077±0.006481). **: 5Li had an improved cell proliferation compared to other two 
groups (P < 0.05) (5Li:1.12825±0.156438; 2Li: 0.82125±0.113953; 0Li:0.7905±0.120876). 
 
5.4.4 Cementum-related and specific genes expression of hPDLCs on Li-MBG 
scaffolds 
5Li-MBG scaffolds showed significantly upregulated expression of the 
mineralization-related genes, such as ALP, OPN and OCN (Fig. 5-5 a, b and c) at 
both day 3 and 7 compared to other two groups (MBG and 2Li-MBG). 5Li-MBG 
scaffolds also had a significant increased expression of the cementum-related 
CEMP1 and CAP genes compared to two other groups at both day 3 and 7 (Fig. 5-5 
d and e). 
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Figure 5-5. The effect of Li contents in MBG scaffolds on bone-related gene expression of 
ALP (a), OPN (b), OCN (c) and cementum-specific markers of CEMP1 (d) and CAP (e) for 
hPDLCs. *: significant difference (p<0.05) for 5Li- MBG group compared to other two 
groups at day 3. **: significant difference (p<0.05) for 5Li- MBG group compared to other 
two groups at day 7. 
5.4.5 Wnt signalling pathway-related gene expression of hPDLCs on Li-MBG 
scaffolds 
RT-qPCR results showed a significantly increased expression of Wnt related genes 
(AXIN2, β-catenin) in the 5Li-MBG scaffold samples compared with the other two 
groups at both day 3 and 7 (Fig. 5-6).  
 
Figure 5-6.The relative AXIN2 (a) and β-CATENIN (b) gene expression for hPDLCs 
cultured in three scaffolds. **: significant difference (p<0.05) for 5mM Li group compared 
to blank control group at day 7. 
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5.4.6 Ion in cell culture medium after culture PDLCs with of Li-MBG scaffolds 
Generally, there are almost no Li ions in MBG scaffolds medium. Li ion 
concentrations increased in the medium with the increase of Li contents in Li-MBG 
scaffolds at all time-points (Table 5-2). 5Li-MBG scaffolds released more Li ions 
than 2Li-MBG and MBG scaffolds. It was also noted that the incorporation of Li into 
MBG scaffolds increased Si ion release. 
Table 5-2. Ions release of Li-MBG scaffolds in DMEM 
Soaking 
time 
Materials Li
-
 (mg/L) PO4
3-
(mg/L) SiO4
4-
(mg/L) Ca
2+
(mg/L) 
1d 0Li-MBG 0 421.44±5.487 68.56±1.098 122.90±4.215 
 2Li-MBG 3.27±0.021 370.22±6.029 112.50±3.458 172.00±4.526 
 5Li-MBG 8.52±0.214 364.26±5.031 109.99±4.921 167.00±3.856 
7d 0Li-MBG 0 407.85±4.938 72.01±3.140 75.42±2.842 
 2Li-MBG 5.33±0.359 276.68±3.526 84.08±4.529 302.70±5.693 
 5Li-MBG 17.28±1.061 308.09±5.148 82.51±2.632 249.40±4.315 
14d 0Li-MBG 0 383.48±5.804 68.50±1.093 50.25±1.578 
 2Li-MBG 8.63±0.642 281.49±4.153 75.68±2.012 111.60±2.103 
 5Li-MBG 16.01±1.073 293.02±4.965 79.38±3.201 66.76±2.065 
5.4.7 The effect of Li
+
 ions on cementum-related and cementum-specific genes 
expression for hPDLCs 
ALP, OPN and OCN gene expression of hPDLCs in 5mM Li
+
 ions was significantly 
upregulated at both day 3 and 7 compared to the control group without Li
+
 ions (Fig. 
5-7a, b and c). Similarly, the relative expression of CEMP1 and CAP was also 
upregulated by 5mM Li ions at day 3 and 7 compared to the control (Fig. 5-7d and 
e). 
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Figure 5-7. The effect of Li ions on gene expression of bone-related genes of ALP (a), OPN 
(b), OCN (c)  and cementum-specific genes of CEMP1(d), CAP (e) for hPDLCs after culture 
for 3 and 7 days. *: significant difference (p<0.05) for 5mM Li group compared to blank 
control group at day 3. **: significant difference (p<0.05) for 5mM Li group compared to 
blank control group at day 7. 
5.4 DISCUSSION 
In this study, Li-MBG scaffolds have been successfully prepared with hierarchically 
large pores (300-500 µm) and well-ordered mesopores (5 nm) by incorporating Li
+
 
ions into the scaffolds. It was further investigated regarding the cell proliferation and 
cementogenic differentiation, including Wnt-related gene expression of hPDLCs 
cultured with Li-MBG scaffolds and Li
+
 ions-containing medium. It was found that 
the incorporation of 5% Li
+
 into MBG scaffolds significantly enhanced cell 
proliferation and cementogenic differentiation, as well as activation of Wnt 
signalling pathway in hPDLCs. It was found that Li
+
 by itself was sufficient to 
promote the cell proliferation, differentiation and cementogenic related gene 
expression in hPDLCs. These results suggest that Li
+
 ions released from biomaterials 
play an important role in enhancing cementogenesis of PDLCs on bioactive scaffolds 
and this biological reaction may be via activation of Wnt signalling pathway.  
Earlier studies have shown that Li
+
 ions could enhance the bone mass in vivo and 
stimulate neuronal differentiation of neural progenitor cells in vitro, but there are no 
(d) 
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reports in which Li
+
 ions have been incorporated into bioactive scaffolds and their 
effect on cell proliferation and differentiation for cementogenesis in periodontal 
tissue engineering applications. In the present study, Li-MBG scaffolds were firstly 
prepared with the polymer sponge method in which some of the Ca in the scaffolds 
was substituted with Li. The Li-MBG scaffolds thus prepared had a steady release of 
Li ions into the surrounding growth medium, which stimulated the cementogenic 
differentiation of PDLCs. The amount of Li
+
 ions released depended on the amount 
of Li
+
 incorporated into the scaffolds in the first place. Previous studies showed that 
low amount of Li (3%) could inhibit apatite mineralization of biomaterials [216]. In 
addition, if Li+ contents are too high, it will result in potential cytoxicity. Therefore, 
in this study, two low contents of Li (2 and 5%) were selected in scaffolds. Li ions 
release from Li-MBG scaffolds supported the cell attachment and proliferation of 
hPDLCs and 5% Li
+
 incorporated into the MBG scaffolds significantly enhanced the 
cell growth and ALP activity.  Most importantly, it was found that the incorporation 
of 5% Li into MBG scaffolds had the effect of significantly enhancing the 
mineralization related gene expression of ALP, OPN and OCN. Previous studies have 
shown that cementum-derived attachment protein (CAP) and cementum protein 1 
(CEMP1) have limited expression in mature cementum matrix of adult periodontium 
and cementoblasts [217-218]. These results showed that the gene expression of these 
cementum-specific makers was enhanced by 5Li-MBG scaffolds. The results suggest 
that Li
+
 ions released from the bioactive MBG scaffolds may play an important role 
in enhancing cementogenic differentiation of PDLCs. To further clarify the 
biological role of Li
+
 ions in the scaffolds, additional studies were conducted to 
investigate what effect Li
+
 ions by themselves could induce the similar biological 
reaction in PDLCs. The results of these experiments further confirmed the 
stimulatory effect of Li
+
 ions on cell proliferation and cementogenic differentiation 
of PDLCs. The incorporation of Li
+
 into bioactive MBG scaffolds therefore appear to 
be a viable means of enhancing the biological response of hPDLCs towards 
cementogenesis in periodontal tissues engineering applications.  
The effect on the Wnt signalling pathway of Li
+
 incorporation into MBG scaffolds 
was investigated in an effort to find possible molecular mechanisms for lithium's 
ability to stimulate cementogenic differentiation of hPDLCs. Axin2, also known as 
Conductin or Axil, is recognised as the most accurate reporter gene in the canonical 
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Wnt pathway since it is a direct target gene of Wnt ligand binding and activation of 
the Wnt signalling pathway [83, 219]. β-catenin is also a critical member of Wntβ-
catenin signalling pathway, although its expression is not directly linked to the 
activation of the Wnt pathway per se, but rather from post translation modifications 
that inhibits its cytoplasmic degradation as the result of the upstream activation of the 
pathway [71-72]. In this study, 5Li-MBG scaffolds had the effect of significantly 
upregulation of WNT-related gene expression (AXIN2 and β-catenin) of PDLCs 
compared to pure MBG and 2Li-MBG scaffolds. The results strongly suggest that Li-
MBG scaffolds upregulated the canonical Wnt signalling of hPDLCs compared to 
the controls. It seems fair to speculate that the mechanism behind the enhanced 
cementogenic differentiation of hPDLCs in the presence of Li-MBG scaffolds may 
be directly linked to the stimulation of Wnt signalling pathway. This study does 
indicate Li-MBG scaffolds have the possibility of stimulating PDLCs differentiation 
into cementoblast-like cells. However, this concept needs to be tested in vivo to 
further demonstrate that an intact functional cementum can be initiated by the 
application Li
+
 ions released from MBG scaffolds. Future studies will focus on the 
modification of the Li-MBG scaffolds for the functional cenmentum regeneration. 
5.5 CONCLUSIONS 
Li-MBG scaffolds with hierarchically large pores (300-500 mm) and well-ordered 
mesopores (5 nm) were prepared by substituting part of the Ca
2+
 ions with Li
+ 
ions in 
manufacture of the scaffolds. Li
+
 ions released from the Li-MBG scaffolds 
significantly enhanced the proliferation and cementogenic differentiation of hPDLCs 
via the activation of Wnt signalling pathway. This study indicates that Li-MBG 
scaffolds have potential for the application of periodontal tissue engineering. 
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Abstract 
It is generally accepted that the accelerated differentiation of tissue cells on bioactive 
materials is of great importance to regenerate the lost tissues. Lithium (Li) ions could 
enhance the in vitro proliferation and differentiation of different progenitor cells by 
activating the canonical Wnt signalling pathway. However, it is unclear whether Li-
containing bioactive ceramics, such as β-tricalcium phosphate (Li-β-TCP), can 
effectively induce the differentiation for different stem cells and present the 
significant osteo/cementostimulation for the regeneration of bone/periodontal tissues. 
Therefore, the aim of this study was to investigate the interactions of human 
periodontal ligament cells (hPDLCs) and human bone marrow stromal cells 
(hBMSCs) with Li-β-TCP bioceramic bulks and their ionic extracts, and further 
explore the osteogenic and cementogenic stimulation of Li-β-TCP bioceramics and 
possible molecular mechanisms. The results showed that Li-β-TCP bioceramic disks 
supported the cell attachment and proliferation, and in general significantly enhanced 
bone/cementum-related gene expression, canonical Wnt signalling pathway 
activation in both hPDLCs and hBMSCs, compared to conventional β-TCP 
bioceramic disks and blank controls. The Li-containing ionic products from 5Li-β-
TCP powders could significantly promote the proliferation and bone/cementum-
related gene expression for both hPDLCs and hBMSCs compared to pure β-TCP 
extracts. Our results suggest that Li-β-TCP bioceramics might be another promising 
biomaterial for bone/cementum regeneration, as they possess excellent in vitro 
osteogenic and cementogenic stimulation property by inducing bone/cementum-
related gene/protein expression of both hPDLCs and hBMSCs. 
Key words: Bioceramics; tissue engineering; bone regeneration; β-tricalcium 
phosphate 
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6.1 INTRODUCTION 
For bone/periodontal tissues regeneration application, it is generally accepted that the 
quick differentiation of tissue cells on bioactive materials is of great importance to 
regenerate the deficient and injured tissues [16, 220-221]. To achieve this target, the 
strategy for applying growth factor to accelerate the differentiation of tissue cells has 
been widely studied [222]; however, the usage of growth factors is highly costly and 
may have potential health risks [223-224]. Hench et al. suggested that the third-
generation of biomaterials should possess the ability to stimulate the differentiation 
of stem cells for tissue regeneration [225-226]. More and more studies have shown 
that bioactive materials with specific bioactive compositions and microstructures can 
induce the differentiation of stem cells and promote tissue regeneration [191, 207, 
215, 227]. For this reason, it is of great importance to prepare proper bioceramics to 
release inorganic stimulus to stimulate the response of stem cells for bone and 
periodontal tissue regeneration without the usage of additional growth factors. It is 
well known that beta-tricalcium phosphate (β-TCP) is the most conventional used 
bioceramics for the regeneration of bone/periodontal tissues due to its high 
osteoconductivity and degradable ability [228-229]; however, there are few reports 
that β-TCP bioceramics can significantly induce the differentiation of stem cells and 
present the significant osteostimulation for the regeneration of bone/periodontal 
tissues. Although β-TCP bioceramics are generally biodegradable and biocompatible, 
they are still far from optimal for stimulating the osteogenic/periodontal 
differentiation of stem cells to achieve further shorten healing time of tissue defects 
[230-233]. In the past several years, bioactive ions (e.g. Sr and Si) modified β-TCP 
bioceramics with improved bioactivity have been prepared for bone regeneration 
application [234-235], which inspired us that bioactive ions modification to β-TCP 
bioceramics may be a viable method to stimulate differentiation of mesenchymal 
stem cells for better tissue regeneration. 
Lithium chloride (LiCl) has been used as a mood stabiliser, which can stimulate the 
proliferation of retinoblastoma cells and endometrium epithelia cells via elevated 
canonical Wnt signalling [236-239]. Another study demonstrated that LiCl greatly 
enhances induced pluripotent stem cells (iPSCs) generation from both mouse 
embryonic fibroblast and human umbilical vein endothelial cells [240]. Previous 
studies showed that Li ions could be incorporated to bioactive glasses to regulate the 
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apatite mineralization and enhance the cementogenic differentiation of human 
periodontal ligament cells (hPDLCs) [216, 241]. However, there is no report about 
the preparation of Li-containing bioceramic, such as β-TCP and whether Li-
containing bioceramics can induce the differentiation of different tissue cells, such as 
human bone marrow stromal cells (hBMSCs) and human periodontal ligament cells 
(hPDLCs) for both bone and periodontal regeneration applications. Furthermore, it is 
still unclear for the related molecular mechanisms in which whether canonical Want 
signalling pathway in the hPDLCs and hBMSC differentiation can be activated by 
Li-containing biomaterials. The effect of Li ions released from biomaterials on the 
bone/cementum-related protein expression of hPDLCs and hBMSCs is also 
unknown. It is believed that multipotent hBMSCs are involved in bone and 
periodontal defect healing [242]. As an attractive cell source for tissue engineering, 
BMSCs are easily available, highly proliferative and multipotent to differentiate into 
osteoblasts, chondrocytes, adipose cells, ligament cells, and neural cells [243-247]. 
hPDLCs are considered to be able to regenerate alveolar bone, periodontal ligament  
and cementum. Activation of osteogenic potential of both hPDLCs and hBMSCs by 
bioactive materials would greatly accelerate the new bone  and cementum formation 
in the bone/periondontal defect site [248].  
Therefore, the main aim of this study is to prepare Li-containing β-TCP bioceramics 
in an effort to improve their osteo/cementogenic capabilities compared to 
conventionally used β-TCP bioceramics, and to further elucidate the involved 
mechanism about the activation of the pro-osteo/cementogenic canonical Wnt 
signalling pathway in hPDLCs and hBMSCs by incorporation of Li ions. To achieve 
this aim, the effect of both Li-β-TCP bioceramic disks and their ionic products on the 
differentiation of hPDLCs and hBMSCs has been systematically explored in 
comparison to conventional β-TCP bioceramics.  
6.2 MATERIALS AND METHODS 
6.2.1 Preparation and characterization of 5Li-β-TCP bioceramic powders and 
disks 
The Li-containing β-TCP (5Li-β-TCP) powders with the chemical composition of 
(Li0.10Ca0.95)3(PO4)2 were synthesized by a chemistry precipitation method using 
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Ca(NO3)2·4H2O, (NH4)2HPO4 and lithium chloride (LiCl) as starting materials, in 
which 5% molar Ca was substituted by Li. The rational of to substitute 5% molar Ca 
was according to previous publication [190]. The solution containing 0.5 M of 
Ca(NO3)2 and LiCl in the designed molar ratio was added dropwise into 0.5 M of 
(NH4)2HPO4 solution while stirring to produce the target (Ca+Li)/P ratio of 1.5 
(stoichiometric for β-TCP). The pH of the solution was maintained between 7.5 and 
8 during precipitation by the aid of ammonia. After the precipitation, the solution 
was aged overnight and then washed sequentially in distilled water and anhydrous 
ethanol, dried at 60 
o
C for 24 h and finally calcined at 800 
o
C for 3 h. Pure β-TCP 
powders were synthesized by similar method without adding LiCl and used for the 
controls. 
To prepare ceramic discs, the synthesized 5Li-β-TCP powders were uniaxially 
pressed at 10 MPa in a mould of Ф10, using 6% polyvinyl alcohol as a binder. The 
green compacts were subsequently sintered in air at 1100 °C for 3 h with a heating 
rate of 2°C/min. Pure β-TCP ceramic discs were prepared by similar method and 
used for the controls. The crystal phase and surface morphology of the sintered 
ceramic discs were characterized by X-ray diffraction (XRD, Geigerflex, Rigaku, 
Japan) and scanning electron microscopy (SEM, FEI Company, USA).  
 
6.2.2 The cell morphology of hPDLCS and hBMSCs on 5Li-β-TCP bioceramic 
disks 
Human periodontal ligament cells (hPDLCs) and human bone marrow stromal cells 
(hBMSCs) were isolated and cultured according to previously published protocols 
[190, 227]. The ethics approval of hPDLCs and hBMSCs in this study was granted 
by the Human Ethics Committee of Queensland University of Technology and The 
Prince Charles Hospital, following informed consent taken from all the participants. 
While, hPDLCs were isolated from the teeth from healthy patients (n=3, 18–25 years 
old) undergoing third molar extraction surgery; hBMSCs were isolated from patients 
(n=3, mean age at 65 years) undergoing elective knee and hip replacement surgery. 
hPDLCs and hBMSCs at the 2-5
th
 passage were seeded on 5Li-β-TCP ceramic disks 
at the initial seeding density of 10
5 
cells per disk in 48-well plates and cultured under 
osteogenic induction medium with the supplement of 0.1μM dexamethasone (Sigma-
Aldrich, Australia), 10mM β-glycerophosphate (Sigma-Aldrich, Australia) and 
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50μg/mL ascorbate-2-phosphate (Sigma-Aldrich, Australia). The cells cultured in β-
TCP ceramics and blank wells were as control in this study. 
The cell morphology on the disks was observed by SEM. The cellular samples were 
fixed in 2.5% glutaraldehyde solution and then dehydrated by graded ethanol series 
(50, 70, 90, and 100%) and dried by hexamethyldisilizane (HMDS). Then, the disks 
were sputter-coated by gold and observed by SEM (Quanta™ 200) for the 
morphological characteristics of hPDLCs and hBMSCs on two ceramics.  
The confocal laser scanning microscopy (CLSM) was carried out to further 
determine the morphology of actin fibres and nuclei of hPDLCs and hBMSCs on the 
two ceremics disks through high-resolution optical images. After 1 and 7 days 
culture, cell-ceramics complex were fixed with 4% paraformaldehyde (PFA) solution 
for 30 mins at room temperature and then was permeabilized with 0.2% Triton X-
100/PBS solution for 5 mins and then rinsed by PBS once. Samples were then 
incubated for 1 hr with 0.5% BSA/PBS containing 0.8 U/ml TRITC conjugated 
phalloidin (Sigma-Aldrich, Australia) and 5 µg/ml DAPI (Sigma-Aldrich, Australia). 
The cells were visualized with Leica SP5 Confocal microscope (Leica Microsystems, 
Germany). 
6.2.3 Cell proliferation and relative alkaline phosphatase (ALP) activity assay for 
hPDLCs and hBMSCs on 5Li-β-TCP bioceramic disks  
For the cell proliferation assay, 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) assay was performed in triplicate as described 
in the previous study protocol [190, 249]. The formazan crystals were formed by 
adding 0.5 mg/mL of MTT solution (Sigma-Aldrich) for 4 hours and then solubilised 
with dimethyl sulfoxide (DMSO, Sigma-Aldrich, Australia). The absorbance of 
formazan-DMSO solution was measured at λ=495 nm by SpectraMax Microplate 
Reader (Molecular Devices, Inc., USA).  
After 7 and 14 days, the relative ALP activity was determined for both cell lines 
cultured on 5Li-β-TCP ceramic disks using previous protocols [191]. At each time 
point, the cells were lysed in 200 μL of 0.2% Triton X-100 and then mixed with ALP 
working solution according to the manufacturer’s protocol (QuantiChromTM Alkaline 
Phosphatase Assay Kit, BioAssay Systems, USA). The optical density (OD) value 
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was measured at 405 nm on a plate reader. The relative ALP activity was calculated 
as the changed OD values divided by the reaction time and the total protein content 
measured by the bicinchoninic acid protein assay kit (Thermo Fisher Scientific, 
Australia). 
6.2.4 Real-time quantitative (RT-qPCR) analysis of cementogenic/osteogenic gene 
expression and signalling pathway for hPDLCs and hBMSCs  
Total RNA was extracted from the cells on 5Li-β-TCP, β-TCP ceramic disks and 
blank wells using TRIzol
®
 Reagent (Ambion
®
, Life Technologies Pty Ltd., 
Australia). RT-qPCR was performed on osteogenic-related markers of alkaline 
phosphatase (ALP), osteopontin (OPN) and osteocalcin (OCN); cementum-related 
markers of cementum protein 1 (CEMP1) and cementum attachment protein (CAP); 
canonical Wnt-related genes of Wingless-3A (WNT3A), axis inhibition protein 2 
(AXIN2), beta-catenin (CTNNB) as shown in Table 6-1. All reactions were conducted 
in triplicate for three independent experiments. The mean cycle threshold (Ct) value 
of target genes was normalized against Ct value of house-keeping gene 
glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) and 18S ribosomal RNA (18S 
rRNA) and then the relative expression was calculated by the following formula: 2
-
(normalized average Cts)
 ×10
4
. 
Table 6-1. Primer pairs used in qRT-PCR analysis 
Gene Forward primer Reverse primer 
ALP 5' TCAGAAGCTAACACCAACG 3' 5' TTGTACGTCTTGGAGAGGGC 3' 
OCN 5'GCAAAGGTGCAGCCTTTGTG 3' 5' GGCTCCCAGCCATTGATACAG 3' 
CEMP1 5' GGGCACATCAAGCACTGACAG 3' 5' CCCTTAGGAAGTGGCTGTCCAG3' 
CAP 5' CTGCGCGCTGCACATGG 3' 5' GCGATGTCGTAGAAGGTGAGCC 3' 
WNT3A 5' TGGACAAAGCTACCAGGGAGT 3' 5' CCCACCAAACTCGATGTCCTC 3' 
AXIN2 5' CCCCAAAGCAGCGGTGC 3' 5' GCGTGGACACCTGCCAG 3' 
CTNNB 5' GCTACTGTTGGATTGATTCGAAATC 3' 5'CCCTGCTCACGCAAAGGT 3' 
GAPDH 5' TCAGCAATGCCTCCTGCAC 3' 5' TCTGGGTGGCAGTGATGGC 3' 
18s 5’ TTCGGAACTGAGGCCATGAT 3' 5’ CGAACCTCCGACTTCGTTC 3' 
6.2.5 Ionic concentration analysis for the cell culture medium after culture 5Li-β-
TCP bioceramic disks 
To investigate the ion release of 5Li-β-TCP ceramics disks, the cell culture medium 
(n=3) was collected after cell culturing of hPDLCs and hBMSCs after the fixed 
culture time; then the ionic concentrations of Li, Ca and P ions in the medium were 
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measured by inductive coupled plasma atomic emission spectrometry (ICP-AES, 
Perkin-Elmer Optima 7000DV).  
6.2.6 The effects of ionic extracts from 5Li-β-TCP powders on cementum/bone-
related protein expression for hPDLCs and hBMSCs  
The effect of ionic extracts from 5Li-β-TCP powders was further investigated on 
osteogenic/cementogenic-related proteins expression of hPDLCs and hBMSCs. 
According to International Standard Organization (ISO/EN) 10993-5 [250], the 
dissolution extracts were prepared by soaking 5Li-β-TCP powders in serum-free 
DMEM at the concentration of 200 mg/mL. Then serial dilutions of extracts (100, 
50, 25, 12.5 and 6.25 mg/mL) were prepared after sterilization using a 0.2 μm filter 
in the following studies. The ionic concentrations of Ca, P and Li in the graded 
extracts were measured by ICP-AES. All experiments were conducted in triplicate. 
After hPDLCs and hBMSCs were cultured with the β-TCP and 5Li-β-TCP extracts, 
respectively, cell proliferation and ALP activity assay was performed as described in 
Section 6.2.3. The RT-qPCR analysis for the cementogenic/osteogenic gene 
expression was performed as described in the Section of 6.2.4. All experiments were 
conducted in triplicate. 
 
6.2.7 Statistical analysis 
The statistical analysis was performed using one-way ANOVA followed by a 
Student’s T-test. A p-value < 0.05 was considered statistically significant.  
6.3 RESULTS 
6.3.1 Characterization of 5Li-β-TCP bioceramic disks 
SEM analysis showed that the prepared both 5Li-β-TCP and β-TCP bioceramics 
were fully sintered with dense surface microstructure and clear crystal boundaries 
(Fig. 6-1). The crystal size in 5Li-β-TCP bioceramics is generally smaller than that of 
β-TCP bioceramics. XRD analysis showed that 5Li-β-TCP ceramics had same 
characteristic peaks as β-TCP ceramics with pure β-TCP crystal phase (JCPD 09-
0169) (Fig. 6-1). 
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Figure 6-1. SEM and XRD analysis analysis for 5Li-β-TCP and β-TCP bioceramics. The 
crystal size in 5Li-β-TCP bioceramics is generally smaller than that of β-TCP bioceramics 
through SEM analysis. 
6.3.2 The cell morphology, proliferation and ALP activity of hPDLCS and 
hBMSCs on 5Li-β-TCP bioceramic disks 
The cell morphology of hPDLCS and hBMSCs was performed by SEM after 7 days 
culturing on 5Li-β-TCP and β-TCP bioceramics. Both hPDLCs and hBMSCs 
attached and spread well on the surface of two ceramic disks with close contact with 
ceramics at day 7 (Fig. 6-2). 
After culture on two bioceramics disks for 7 days, CLSM was carried out to further 
confirm the morphology for both hPDLCs and hBMSCs were healthy and attached 
on the surface of disks very well (Fig. 6-3). 
The MTT assay showed that the proliferation of both hPDLCs and hBMSCs 
increased obviously in a time dependent manner in each group. The proliferation rate 
 Chapter 6: Design of lithium-containing TCP for cementogenic differentiation 97 
of hPDLCs on 5Li-β-TCP bioceramics disks was significantly higher than that on β-
TCP ceramics at both day 1 and 7 (Fig. 6-4). 5Li-β-TCP than that on β-TCP ceramics 
groups at day 1, 3 and 7 (Fig. 6-4). 
 
Figure 6-2. The cell morphology for (a) hPDLCs on 5Li-β-TCP, (b) hBMSCs on 5Li-β-
TCP, (c) hPDLCs on β-TCP and (d) hBMSCs on β-TCP bioceramics after culturing for 7 
days.  
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Figure 6-3. The confocal fluorescent images for hPDLCs  and hBMSCs on β-TCP and 5Li-
β-TCP bioceramics after culture for 7 days. 
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Figure 6-4. The cell proliferation and relative ALP activity for hPDLCs (a, c) and hBMSCs 
(b, d) on β-TCP and 5Li-β-TCP bioceramics. *: significant difference (p<0.05) for 5Li-β-
TCP group compared to β-TCP group with respect to cell proliferation rate. **: significant 
difference (p<0.05) for 5Li-β-TCP group compared to β-TCP group regarding relative ALP 
activity. 
 
The relative ALP activity of hPDLCs on the 5Li-β-TCP ceramics showed a 
significant increase compared to β-TCP group at both 7 and 14 days (p<0.05, Fig. 6-
4). 5Li-β-TCP ceramics enhanced the relative activity of ALP in hBMSCs compared 
to other two groups at day 14. 
6.3.3 Cementogenic/osteogenic gene expression of hPDLCs and hBMSCs on 5Li-
β-TCP bioceramic disks 
At day 7, RT-qPCR analysis showed that the 5Li-β-TCP ceramic disks significantly 
stimulated bone-related genes expression of ALP, OCN and cementum-specific genes 
of CEMP1 and CAP compared to those of other groups for both hPDLCs and 
hBMSCs. 5Li-β-TCP ceramics could significantly enhance the osteogenic/ 
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cementogenic gene expression for both hPDLCs and hBMSCs compared to β-TCP 
ceramics (Fig. 6-5).  
 
Figure 6-5. The bone-related gene expression of ALP, OCN and cementum-specific markers 
of CAP and CEMP1for hPDLCs (a, c, e, g) and hBMSCs (b, d, f, h) on β-TCP and 5Li-β-
TCP bioceramics. *: significant difference (p<0.05) for 5Li-β-TCP group compared to β-
TCP group at day 3. **: significant difference (p<0.05) for 5Li-β-TCP group compared to β-
TCP group at day 7. 
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6.3.4 Wnt-related signalling gene expression for hPDLCs and hBMSCs on 5Li-β-
TCP bioceramic disks 
The analysis of the expression of canonical Wnt-related genes such as WNT3A, 
AXIN2 and CTNNB was performed by RT-PCR after culturing both hPDLCs and 
hBMSCs on two ceramics disks and blank group for 3 and 7 days. The results 
showed that the expression of WNT3A and AXIN2 of both hPDLCs and hBMSCs on 
5Li-β-TCP bioceramics was significantly higher than β-TCP ceramics group at day 7 
(Fig. 6-6).   
 
Figure 6-6. The canonical Wnt-related gene expression of WNT3A and AXIN2 for hPDLCs 
(a, c) and hBMSCs (b, d) on β-TCP and 5Li-β-TCP bioceramics. *: significant difference 
(p<0.05) for 5Li-β-TCP group compared to β-TCP group at day 3. **: significant difference 
(p<0.05) for 5Li-β-TCP group compared to β-TCP group at day 7..  
6.3.5 Ionic concentration analysis for the cell culture medium after culture 5Li-β-
TCP bioceramic disks 
It was noted that there is no Li ion release in DMEM and β-TCP medium. However, 
there were obvious Li ions in the medium released from 5Li-β-TCP bioceramic disks 
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culture for hPDLCs (Table 6-2) and hBMSCs (Table 6-3) at day 3, 7 and 14. 
Interestingly, the released Li ions from hBMSCs cultured on 5Li-β-TCP disks were 
more than that from hPDLCs cultured on 5Li-β-TCP disks. There was no significant 
difference for P ions between 5Li-β-TCP and β-TCP groups cultured with two cells; 
however, the concentrations of Ca ion for 5Li-β-TCP was a slightly lower than those 
for β-TCP groups cultured with two cells (Table 6-2 and 6-3).  
Table 6-2 Ions release of 5Li-TCP ceramic disks in DMEM cultured with hPDLCs 
Table 6-3. Ions release of 5Li-TCP ceramic disks in DMEM cultured with hBMSCs 
 
6.3.6 The effects of ionic extracts from 5Li-β-TCP powders on bone/cementum-
related protein expression of hPDLCs and hBMSCs  
The ionic concentrations of Li, Ca and P in the extracts from β-TCP and 5Li-β-TCP 
powders were shown in Table 5. At the concentration of 200 mg/mL, it was obvious 
that the Li concentrations reached 7.42 mg/L; however, there were no Li ions in β-
TCP extracts (Table 6-4). The concentrations of Ca and P ions in β-TCP and 5Li-β-
TCP groups were comparable. 
Culture 
time 
Materials Li (mg/L) P(mg/L) Ca(mg/L) 
3d 
DMEM 0 323.9±5.148 78.03±0.505 
β-TCP  0 304.1±1.374 65.37±0.243 
5Li-β-TCP 0.34±0.013 301.2±1.172 62.58±0.183 
7d 
DMEM 0 295.4±0.751 75.38±0.259 
β-TCP 0 280.4±2.051 65.12±0.41 
5Li-β-TCP 0.44±0.019 272±1.223 63.14±0.295 
14d 
DMEM 0 221.4±2.479 76.99±0.551 
β-TCP 0 203.2±1.305 67.87±0.805 
5Li-β-TCP 0.34±0.026 205.5±1.375 59.02±0.125 
Culture time Materials Li(mg/L) P(mg/L) Ca(mg/L) 
3d 
DMEM 0 317±3.2 74.94±0.832 
β-TCP 0 285.6±1.986 62.55±0.036 
5Li-β-TCP 1.23±0.014 281.7±5.773 54.89±0.249 
7d 
DMEM 0 290.2±1.589 67.26±0.815 
β-TCP 0 269.5±0.702 62.59±0.206 
5Li-β-TCP 0.89±0.047 269.3±0.611 57.8±0.449 
14d 
DMEM 0 206.1±0.989 59.85±0.651 
β-TCP 0 203.4±1.617 65.63±0.305 
5Li-β-TCP 0.79±0.046 205.4±1.127 59.38±1.463 
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Figure 6-7. The proliferation for hPDLCs (a) and hBMSCs (b) after culture different 
concentrations of β-TCP and 5Li-β-TCP powder extracts for 7 and 14 days. *: significant 
difference (p<0.05) for 5Li-β-TCP group compared to β-TCP group at day 7.  
 
Figure 6-8. The relative bone-related gene expression of ALP, OCN and cementum-specific 
markers of CEMP1 for hPDLCs (a, c, e) and hBMSCs (b, d, f) after culturing with different 
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concentrations of β-TCP and 5Li-β-TCP extracts for 7 days. *: significant difference (p<0.05) 
for 5Li-β-TCP group compared to β-TCP group.  
Table 6-4. The ionic concentrations of the extracts from β-TCP and 5Li-β-TCP powders 
As determined by MTT assay, the cell proliferation rate of both hBMSCs and 
hPDLCs was significantly higher cultured in presence of 5Li-β-TCP extracts with a 
wide range of concentrations (200, 100, 50 and 6.25mg/mL) than that cultured with 
β-TCP group at day 7 (Fig. 6-7a, b).  
Results of bone/cementum-related gene expression analysis of ALP, OCN and 
CEMP1 showed that the 5Li-β-TCP extracts at all the range concentrations enhanced 
hPDLCs osteogenic and cementogenic differentiation compared to β-TCP extracts 
group at day 7 (Fig. 6-8a, c, e). At day 7, the expression of ALP for hBMSCs was 
reduced when cultured with 5Li-β-TCP at the concentration of 200 and 50mg/mL 
compared to those grown in β-TCP extracts (Fig. 6-8b). The expression of OCN and 
CEMP1 for both hPDLCs and hBMSCs was increased by 5Li-β-TCP extracts at all 
the range concentrations compared with that in β-TCP extracts group (Fig. 6-8c-f).  
6.4 DISCUSSION  
The present study conducted a systematic investigation of the cell attachment, 
proliferation, bone/cementum and canonical Wnt related gene expression for both 
hPDLCs and hBMSCs cultured on 5Li-β-TCP ceramic disks or with 5Li-β-TCP 
powder extracts. To our best knowledge, this was the first study in preparation of Li-
containing β-TCP bioceramics. Li ions have been successfully incorporated into β-
TCP by a conventional chemical precipitation method. The results showed that the 
incorporation of 5% Li into β-TCP bioceramics did not change the crystal phase 
structures. ICP analysis for both Li-β-TCP ceramics disks and powder extracts 
further confirmed that Li ions had been incorporated into β-TCP.  
Extract 
concentrations 
(mg/mL) 
Materials Li(mg/L) P(mg/L) Ca(mg/L) 
200mg/mL 
β-TCP 0 205.1±3.156 55.53±1.056 
5Li-β-TCP 7.42±0.046 202.2±1.011 54.45±1.752 
50mg/mL 
β-TCP 0 291.3±3.125 71.3±2.024 
5Li-β-TCP 1.86±0.023 290.5±4.235 71.0±1.652 
6.25mg/mL 
β-TCP 0 316.3±5.321 75.9±1.365 
5Li-β-TCP 0.23±0.009 316.4±4.216 75.8±0.956 
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It is well known that hBMSCs can be potentially used for regenerating and repairing 
bone defects that normally cannot undergo spontaneous healing [251-252]. hPDLCs, 
another population of mesenchymal cells, have shown a promising potential for 
periodontal regeneration as they are easily isolated from the patients’ tooth 
extractions [253]. Many studies suggested that conventional β-TCP bioceramics have 
been proven to be osteoconductive for bone/periodontal regeneration application 
[143, 254-258]; Li ions could enhance the in vitro cell proliferation and osteogenic 
differentiation by activating their canonical Wnt signalling pathway. However, it 
remains unclear whether Li-β-TCP bioactive ceramics can be used for potential bone 
and cementum regeneration. In this study, the cells cultured on β-TCP bioceramic 
disks were used for controls. Our results showed that both hPDLCs and hBMSCs are 
well attached on the surface of 5Li-β-TCP and β-TCP bioceramics through SEM and 
CLSM analysis.  
ALP is known as an early marker for osteoblastic differentiation; OCN is another 
important gene related to the bone mineralization [259-260]. CEMP1 and CAP are 
the cementum-specific markers which have been identified to have limited and 
specific expression in cementum or cementum-like tissues [217-218, 261]. Our 
results showed that 5Li-β-TCP had enhanced ostegenic and cementogenic 
differentiation for both cell lines over time, suggesting it is reasonable that gene 
activity is not always matched with enzyme activity. These data indicate that 5Li-β-
TCP ceramic disks possess excellent in vitro osteogenic and cementogenic 
stimulation for both hPDLCs and hBMSCs. However, in our study, hPDLCs showed 
a slightly enhanced proliferation rate than that of hBMSCs which may be due to the 
age difference from the donor donated periodontal ligament and bone marrow 
stromal cells (i.e. 18-25 vs. 65 years). 
Strontium (Sr) is an element proposed to induce bone and previous studies have 
indicated that Sr might have a positive effect on bone formation by inhibiting bone 
resorption and through enhancing endosteal and trabecular bone formation [262-
265]. Silicon/strontium (Si/Sr)-containing β-TCP ceramics have been proved to 
stimulate bone cell proliferation and osteogenic differentiation by releasing Si/Sr 
ions products [234, 266]. There are increasing studies about the stimulatory effect of 
Sr
2+
 ions on the osteogenic differentiation of osteoblast-like cell and regeneration of 
lost bone [267]. It was reported that Si-containing β-TCP bioceramics had enhanced 
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osteogenic differentiation through increasing relative ALP activity and bone-related 
gene expression (Col1a, BSP and OCN et al.) for hBMSCs by 0.5-1 fold change 
compared to β-TCP only [268-269]. Li is another element and it is reported that Li 
may enhance fracture healing in mice, while clinically it reduces the incidence of 
fractures with increasing clinical accumulated dose use of Li. In this study, Li
+
 ions 
released from 5Li-β-TCP biomaterials had an increased osteogenic and cementogenic 
differentiation for both hPDLCs and hBMSCs in a general trend. Notably, Li
+
 ions 
could stimulate canonical Wnt signalling pathway, suggesting 5Li-β-TCP biomaterial 
could be potentially applied for periodontal regeneration due to its excellent 
osteogenic/cementogenic differentiation via activation of canonical Wnt signalling 
pathway. 
It is known that the chemical composition and surface property of bioceramics are 
two important factors to influence cell response. Our results showed that the 
incorporation of Li into β-TCP ceramic disks did not influence the surface 
morphology [241, 270-273]. Previous study showed the crystal size of biocramics 
also significantly influenced the cell attachment and proliferation [274-275].  
Therefore, it is reasonable to speculate that the decreased crystal size of Li-
containing β-TCP ceramics may be the other important factor to influence the cell 
differentiation. In this study, 5Li-β-TCP ceramics have smaller particles size and 
grains which may influence the cell differentiation. While the crystal sizes is still in 
the range for the cells ingrowth and differentiation. To further investigate whether 
the composition of 5Li-β-TCP may play the key role to stimulate 
osteogenic/cementogenic differentiation of hPDLCs and hBMSCs, the ionic extracts 
of 5Li-β-TCP powders were prepared, which mainly contains Li+, Ca2+ and PO4
3-
 
ionic products dissolved from 5Li-β-TCP (Table 6-5). Similar results were obtained, 
ionic products from 5Li-β-TCP also significantly promoted bone/cementum-related 
gene expression of both hPDLCs and hBMSCs. Therefore, it is reasonable to 
speculate that the Li-containing ionic products play an important role to stimulate 
osteogenic/cementogenic differentiation for both hPDLCs and hBMSCs. It is known 
that effect of LiCl has a dose-dependence manner on cell proliferation and 
differentiation. Recent findings showed that osteogenic differentiation of primary 
osteoblasts was enhanced by LiCl at the concentration of 1 mM [276]; however, 
higher concentrations of 10 mM showed inhibited effect for osteoblastic 
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differentiation [277]. In this study,   Li
+
 ions concentration was only 0.2 mM released 
from 5Li-β-TCP bioceramic disks; however, it showed higher Li+ ions release with 
the concentration of 1.1mM when 5Li-β-TCP extracts were at the concentration of 
200 mg/L. Therefore, the concentration range for Li ions is around 0.2-1.1mM, 
which is comparable to that reported by Galli et al. We further analysed the ionic 
composition of cell culture medium for β-TCP and 5Li-β-TCP ceramic disks. 
Interestingly, it is also found that the concentrations of Li
+
 ions in the culture 
medium containing 5Li-β-TCP ceramic disks with hPDLCs are obviously lower than 
those with hBMSCs as shown in Table 2 and 3. The possible reason is that the 
different cell types may lead to different surface dissolution in the microenvironment 
of cell and material surfaces. Furthermore, two types of cells may also possess 
different up-taking ability for Li
+
 ions. The pH value of cell culture medium with 
hBMSCs was slightly lower than that of hPDLCs. The lower pH value may be the 
main reason to improve the Li
+
 ions release from materials. However, further study is 
needed to confirm the difference between hPDLCs and hBMSCs on these material 
surfaces. 
The effect of 5Li-β-TCP bioceramics on the Wnt signalling pathway for both 
hPDLCs and hBMSCs was further investigated to explore possible underlying 
mechanisms for 5Li-β-TCP bioceramics to stimulate osteogenic/cementogenic 
differentiation of hPDLCs and hBMSCs. The Wnt signalling pathway plays a major 
role in various processes during development including cell proliferation and 
differentiation [278]. WNT3a is a secreted glycoprotein that interacts with cell 
membrane-associated proteins and plays an important role in intracellular canonical 
Wnt signal transduction through the phosphorylation and accumulation β-catenin, 
which is another critical member of Wnt/β-catenin signalling pathway [243, 279]. 
Axin2, also known as axin-like protein (Axil) or axis inhibition protein 2 (Axin2), is 
recognised as the most accurate reporter gene in the canonical Wnt pathway since it 
is a direct target gene of Wnt ligand binding and activation of the Wnt signalling 
pathway [83]. Up to date, there are few reports involving the interaction of the 
canonical Wnt signalling and hPDLCs osteogenic differentiation. Our results showed 
that 5Li-β-TCP bioceramics significantly enhanced the Wnt canonical-related genes 
expression (WNT3A and AXIN2) of both hPDLCs and hBMSCs compared to β-TCP 
bioceramics, suggesting that Li
+
 ions from 5Li-β-TCP ceramics may be involved in 
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the activation of canonical Wnt signalling pathway for enhancing the 
osteogenic/cementogenic differentiation. 
It is known that Li
+
 ionic concentrations within a certain range concentrations (1mM-
10mM) can induce cell proliferation and osteogenic differentiation. In this study, the 
Li
+
 ions concentrations of 5Li-β-TCP extracts were ranging from 0.03 mM to 1.1 
mM; while there was only approximately 0.05 mM and 0.1 mM with culturing 
hPDLCs and hBMSCs on 5Li-β-TCP bioceramics, which is over the optimal range 
concentrations. This may lead to contradictory results for relative ALP activity and 
proliferation for 5Li-β-TCP extracts and 5Li-β-TCP bioceramics. However, our 
results showed a general enhanced trend on 5Li-β-TCP bioceramics for gene 
expression of key osteogenic and cementogenic differentiation markers compared to 
that of β-TCP bioceramics, suggesting that 5Li-β-TCP bioceramics might be a 
promising biomaterial for periodontal tissue engineering. 
 
Figure 6-9. Schematic illustration for the effect of 5Li-β-TCP bioactive ceramics on 
osteogenic and cementogenic differentiation of both hPDLCs and hBMSCs. 
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Therefore, it is speculated that 5Li-β-TCP bioceramics possess strong 
osteogenic/cementogenic stimulation property for promoting the bone/cementum-
related gene expression. The scheme illustration for the possible mechanism was 
shown in Figure 6-9, in which canonical Wnt signalling pathways in both hPDLCs 
and hBMSCs have been distinctively regulated by 5Li-β-TCP bioceramics. However, 
this concept needs to be further investigated by other Wnt pathway regulators and a 
future in vivo evaluation of bone/cementum forming capacity is also needed to 
demonstrate that the 5Li-β-TCP bioceramics scaffolds can initiate bone/cementum 
regeneration. 
6.5. CONCLUSION 
In summary, Li-containing β-TCP bioceramics were successfully prepared. 5Li-β-
TCP bioceramics supported cell attachment and proliferation, and significantly 
enhanced bone/cementum-related gene expression maybe via the regulation of 
canonical Wnt signalling pathways in both hPDLCs and hBMSCs. Li-β-TCP 
bioceramics show potential application in bone/cementum tissue regeneration due to 
their distinctively osteogenic and cementogenic stimulation property.  
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Chapter 7: Conclusion and Discussion 
7.1 INTRODUCTION  
Periodontal regeneration is a complex physiological process requiring spatial and 
temporal coherence for the coordinated formation of alveolar bone, cementum, and 
functional periodontal ligament [280]. Periodontal tissue regeneration entails the 
induction of cementogenesis along the exposed and denuded root surfaces with 
newly-generated Sharpey’s fibres inserted [281-282]. However, despite considerable 
research efforts in this area, regeneration of the periodontium remains a subject of 
intense interest to dentists and dental scientists, with the molecular and cellular bases 
of PDL formation, repair, and regeneration still poorly understood [283]. Therefore, 
it is of great importance to better understand the molecular mechanism underlying in 
this condition in order to develop therapies capable of regenerating the periodontium. 
In order to achieve these periodontal regeneration outcomes, the specific biological 
factors responsible for periodontal tissue regeneration, must be identified and 
targeted. The initial rationale for this project was to investigate the role of particular 
cell signalling pathway during periodontal regeneration, especially regarding 
cementum regeneration, and then to test their ability to aid periodontal regeneration 
tissue engineering. 
Among cellular signallings, the canonical Wnt signalling pathway has been proven to 
play essential roles in cell maintenance, proliferation and differentiation during the 
entire tooth development including embryonic odontogenesis and tooth root 
formation. There is a direct relationship between tissue induction and morphogenesis 
in embryonic development and postnatal tissue regeneration; fracture repair may be 
considered to recapitulate events that occur in the normal course of embryonic 
development. In this study, it was also investigated whether the canonical Wnt 
signalling pathway might be responsible for cementum regeneration in vivo and 
cementogenic differentiation in vitro, and whether the canonical Wnt signalling can 
work in combination with biomaterials for cementum/ periodontal regeneration tissue 
engineering.   
At the time that this project was conceived, several reports had been made efforts to 
 112 Chapter 7: Conclusion and Discussion 
understand the interaction between the Wnt signalling pathway and cementum 
regeneration in vivo; although several findings demonstrated that apparent 
periodontal regeneration is present at a macroscopic observation scale. This project 
sought to investigate the activation of canonical Wnt signalling, both in a rat 
periodontal defect animal model in vivo and human periodontal ligament cells culture 
in vitro, with respect to the cementum regeneration and the molecular mechanism 
underlying this process at a cellular level. The ultimate goal was to apply the 
canonical Wnt signalling pathway in cementum regeneration tissue engineering 
combined with biomaterials as a potential treatment carrier and strategy to regenerate 
periodontal tissues. 
7.2 THESIS DESIGN  
Firstly, in Chapter 4 of this thesis, activation of the Wnt signalling pathway was 
highlighted with respect to cementum repair using a rat periodontal defect model. 
The objective of this study was to evaluate the role of canonical Wnt signalling 
during primary periodontal healing progress after periodontal defect surgery. 
Successful rat periodontal defect was established until the root surface exposed as 
seen by macroscopic and micro-CT observation. The canonical Wnt signalling 
pathway was locally activated in the periodontal defect area by local injection of the 
canonical Wnt activators (LiCl and Scl-Ab) or LV-Ctnnb. The findings from this 
study indicated that local activation of Wnt signalling can induce significant new 
cementum formation and well-organized periodontal ligament fibres, suggesting a 
vital role for canonical Wnt signalling during cementum regeneration. Subsequently, 
another interesting finding from Chapter 4 was that activation of Wnt signalling by 
LiCl and LV-Ctnnb could promote hPDLCs differentiation towards cementogenic 
with enhanced expression of cementum-related markers, which hints at a possibility 
that canonical Wnt signalling can stimulate the PDL fibres to form cementum in vivo 
and in vitro. However, this concept still requires further confirmation by different 
aspects of experiments that will be discussed in details in the following section of 
“limitation and future direction”. 
Due to Scl-Ab are growth factors with short half-life and being costly, whereas LiCl 
is inexpensive and easier to be controlled. Thus, LiCl was performed as main 
character in next two chapters as LiCl showed similar promising results with induced 
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cementum regeneration with Sharpey’s fibres compared to that from Scl-Ab 
injection. The general purpose of Chapter 5 was to design possible suitable 
biomaterials for periodontal/cementum regeneration tissue engineering. Li
+
 ions were 
incorporated into the mesoporous bioactive glass (MBG) scaffolds to activate 
canonical Wnt signalling in the scaffolds. It showed that Li-MBG scaffolds possess a 
favorable composition, microstructure and mesopore properties for cell attachment, 
proliferation, and cementogenic differentiation of human periodontal ligament-
derived cells (hPDLCs). The findings in this part indicate that incorporation of Li
+
 
ions into bioactive scaffolds is a viable means of enhancing canonical Wnt signalling 
pathway to stimulate cementogenic differentiation of hPDLCs, suggesting that Li-
containing MBG scaffolds might have potential for the application of periodontal 
tissue engineering. 
In Chapter 6, the aim of this study was to investigate the interactions of human 
periodontal ligament cells (hPDLCs) and human bone marrow stromal cells 
(hBMSCs) with Li-β-TCP bioceramic bulks and their ionic extracts, and further 
explore the osteogenic and cementogenic stimulation of Li-β-TCP bioceramics and 
possible molecular mechanisms. To our best knowledge, this study was the first 
study in preparation of Li-containing β-TCP bioceramics and investigated the effect 
of Li-β-TCP bioceramics on cementogenic/osteogenic differentiation for both 
hPDLCs and hBMSCs. The results indicate that the stimulatory effect of 5Li-β-TCP 
bioceramics on the osteogenic/cementogenic differentiation of hPDLCs and 
hBMSCs is related to the regulation of canonical Wnt signalling pathway. This study 
provides some insight into the notion that hBMSC might be another alterative cell 
source for periodontal tissue engineering. The results suggest that 5Li-β-TCP 
bioceramics possess excellent osteogenic/cementogenic stimulation property for both 
hPDLCs and hBMSCs and can be a promising bioactive material for bone/ 
periodontal tissue regeneration. 
Taken together, it is the first time in this report that local injection of LiCl, Scl-Ab 
and LV-Ctnnb improve periodontal regenerative therapy with new cementum 
formation in vivo through activation of canonical Wnt signalling. The observations 
from this work suggest that canonical Wnt signalling plays a vital role during 
cementum regeneration in vivo and in vitro. Importantly, it demonstrated that 
activation of canonical Wnt signalling can induce significant cellular cementum 
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formation in a rat periodontal defect model, which highlights the novelty of potential 
periodontal tissue engineering applications. More interestingly, these results revealed 
that Li-MBG and Li-β-TCP biomaterials can induce the cementogenic differentiation 
of hPDLCs in vitro, via activation of canonical Wnt signalling pathway, suggesting 
they may be promising bioactive materials for cementum regeneration. Based on the 
results in the present study, strategies directly targeting Wnt signalling pathway may 
provide new approaches for periodontal regenerative tissue engineering. 
7.3 LIMITATIONS OF PRESENT STUDY  
The limitation of the particular research approach in this study has been addressed in 
each part of this work. One overarching limitation, however, related to the ability to 
form more new cementum in vivo as the original cementum in rat is only a thin layer 
along the tooth root. The cementum-specific markers are not defined which make it 
challenging to confirm the newly-formed mineralized tissues along the tooth root 
surface possess physiological functions of cementum. I did perform a combination of 
different experimental approaches in order to validate the findings to observe the 
formation of new cellular cementum; however, other new approaches are still needed 
to further confirm the newly-formed cementum can mimic the function of 
physiological cementum. Furthermore, it demonstrated Li-MBG and Li-β-TCP 
biomaterials can be promising periodontal regeneration in vitro; it is still unclear 
whether they can be applied in vivo to induce new cementum formation via 
activation of canonical Wnt signalling pathway. In addition, it is still unknown if 
canonical Wnt signalling pathway had cross talk with other signalling pathways 
during periodontal regeneration. 
7.4 FUTURE DERECTIONS  
In this thesis, it is noted that activation of canonical Wnt signalling can induce new 
cementum regeneration in vivo, with the aid of a local injection with the concern 
concentration of LiCl, anti-sclerotin antibody and LV-Ctnnb at the periodontal defect 
area. However, it is unknown whether other concentrations of these two reagents still 
have the same effect for cementum regeneration and whether they would be toxic for 
the tissues around the defect area. Therefore, further studies are required to identify 
such issues, probably by local injection of different concentrations of LiCl and anti-
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sclerotin antibodies using the same rat periodontal defect model. 
In addition, additional studies should be designed to understand whether there is a 
cross talk between canonical Wnt signalling and other soluble molecules during the 
cementum regeneration progress. It is of great interest to identify whether there is 
any potential link between cementum regeneration and other signalling networks 
including the Bmp signalling pathway, Fgf signalling pathway and Hh signalling 
pathways. Furthermore, it is of great importance to test, whether the newly-formed 
cementum has the same mechanical properties as physiological cementum. 
Subsequently, the chemical components analysis of newly-formed cementum needs 
to be analysed to determine whether the newly-formed cementum can function well 
uner normal physiological conditions in vivo. 
As mentioned previously, Li-MBG and Li-β-TCP biomaterials can significantly 
enhance the cementogenic differentiation of hPDLCs in vitro via activation of 
canonical Wnt signalling pathway. However, it is still unclear whether these 
materials can induce new cementum formation in vivo. An animal study would also 
have to be designed to investigate the potential efficacy of these biomaterials in 
relation to cementum regeneration in vivo conditions. 
7.5 CONCLUDING REMARKS  
The study presented in this thesis highlights the important role of canonical Wnt 
signalling pathway during cementum regeneration in vivo and in vitro; and that Li-
MBG and Li-β-TCP biomaterials may be promising bioactive materials for 
cementum/periodontal tissue engineering via activation of canonical Wnt signalling. 
A systematic targeting of this molecular event by canonical Wnt signalling pathway 
may provide a new scientific rationale for the potential development of novel 
therapeutic strategies for periodontal diseases treatment. 
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